<TABLE>
<TR><TD COLSPAN=5><a name="description"></a>&nbsp;<p><p align='CENTER'><strong> 8.A.23 The Basigin (Basigin) Family</strong></p>
<p><span style='font-family: Times;'> Basigin precursor protein of humans is also called CD147, 5F7, emmprin, leukocyte activation antigen, MP, (tumor-derived) collagenase stimulating factor, and extracellular matrix metalloproteinase inhibitor.  It is a chaperone glycoprotein with an N-terminal leader peptide that is probably removed by proteolysis after secretion.  It has a second TMS near its C-terminus.  Additionally, it has two IG<sub>can</sub></span> immunoglobulin-like cell adhesion domains (positions 20-110 and 220-310).  The protein directs transporters such as MCT1, MCT2. MCT3 amd MCT4 but not MCT8 (2.A.1.13) to the plasma membrane and remains bound to them, being required for activity and for sensitivity to inhibition by organomercurials (<a class='reflink' href='#ref3259'>Wilson <em>et al</em>., 2005; <span id='ref9791.23506875' class='cite'>Halestrap 2013</span></a>).&nbsp; It appears to regulate complex I activity and apoptosis in mitochondria by
interacting with mitochondrial NDUFS6 (<span id='ref34544355.25470292' class='cite'>Luo <em>et al.</em> 2014</span>).&nbsp; It has many homologues in vertebrate and invertebrate animals, and several of these have been functionaly characterized. The role of basigin in regulating many transporters has been reviewed (<span id='ref34544895.26684586' class='cite'>Muramatsu 2016</span>). The basigin Ig-I domain mediates interactions with monocarboxylate transporters (MCTs, TC# 2.A.1.13) which are required for the transporter to reach the plasma membrane during biogenesis and also affects the activities of these transporters (<span id='ref34552900.33770122' class='cite'>K&ouml;pnick <em>et al.</em> 2021</span>). <em>Plasmodium yoelii</em> erythrocyte binding like protein interacts with basigin, an erythrocyte surface protein (<span id='ref34553102.33937099' class='cite'>Yuguchi <em>et al.</em> 2021</span>).</p>
<p>Basigin is the receptor for
cyclophilins, S100A9, and platelet GPVI, while basigin-1 serves as the receptor for the rod-derived
cone viability factor (<span id='ref34544895.26684586' class='cite'>Muramatsu 2015</span>). As noted above, basigin tightly associates with monocarboxylate transporters, and is
essential for their cell surface translocation and activities, but&nbsp; it
also associates with other proteins including GLUT1, CD44, and CD98. The carbohydrate portion is recognized by lectins, such as galectin-3 and E-selectin. These molecular recognitions
form the basis for the role of basigin in the transport of nutrients, migration of inflammatory
leukocytes, and induction of matrix metalloproteinases. Basigin is important in vision,
spermatogenesis, and other physiological phenomena, and plays roles in the pathogenesis
of numerous diseases, including cancer. It is also the receptor for an invasive protein RH5,
which is present in malaria parasites. Loss of Basigin expression in uterine cells leads to subfertility in female mice (<span id='ref34553463.34106247' class='cite'>Li <em>et al.</em> 2021</span>).&nbsp; Full activation of thermogenesis in brown adipocytes requires Basigin action (<span id='ref34557485.36595342' class='cite'>Rupar <em>et al.</em> 2023</span>).&nbsp;&nbsp; Basigin mediation of  <em>Plasmodium falciparum</em> red blood cell invasion does not require its transmembrane domain or interaction with monocarboxylate transporter 1 (<span id='ref34557775.38315723' class='cite'>King <em>et al.</em> 2024</span>).</p>
<p>Contactin 2, a glycosylphosphatidylinositol-anchored neuronal membrane protein, and another transmembrane protein called contactin associated protein-like 2 (CNTNAP2 alias CASPR2) are together necessary to maintain voltage-gated potassium channels at the juxtaparanodal region. CNTN2 knockout mice were previously reported to suffer from spontaneous seizures and mutations in the CNTNAP2 gene have been described to cause myoclonic tremor and epilepsy in humans (<span id='ref9784.23518707' class='cite'>Stogmann <em>et al.</em> 2013</span>).</p>
<p>The rat liver C-BAT is a 110 kDa glycoprotein (GP110) of 519 amino acids. Its short C-terminus is in the cytoplasm, it spans the membrane once, and the majority of the protein is external. It contains the ATP-binding consensus site (residues 92-100) of GPAYSGRET and is an ecto-ATPase. Transfection of heterologous cells with the cDNA encoding this protein conferred both bile acid transport and ecto-ATPase activity to the recipient cells (<span id='ref9789.8420979' class='cite'>Sippel <em>et al.</em> 1993</span>; <span id='ref9790.8300615' class='cite'>1994</span>). Taurocholate is pumped out of the cell. Transport (but not ATPase activity) appears to be stimulated by protein kinase C-mediated phosphorylation of the C-terminal domain. The ecto-ATPase activity of this protein does not appear to mediate transport although reduction in the cytoplasmic ATP concentration reduces the transport rate. Both ATP and the membrane potential have been implicated as energy sources for transport.</p>
<p>The topology of the rat liver C-BAT protein as a Type I membrane protein, the dissection of its transport activity from its ecto-ATPase activity, its homology to members of the carcinogenic antigen superfamily and its identification as a calcium-independent cell adhesin in the apical membrane of the hepatocyte all suggest that this protein does not alone function as a bile acid efflux pump (<span id='ref9788.9068608' class='cite'>Suchy <em>et al.</em> 1997</span>). The involvement of at least one other protein is suggested, and this other protein may be the primary bile acid export permease. GP110 may thus be an accessory protein, possibly an activator that is responsive to protein kinase<a class='reflink' href='#ref9791'> (Halestrap 2013</a>).&nbsp; CD147/Basigin Is involved in the development of malignant tumors and T-cell mediated immunological disorders via regulation of glycolysis (<span id='ref34557864.38139173' class='cite'>Kanekura 2023</span>).</p>
<p>Neuroplastins are homologous to and function like basigins. Of these, both np65 and np55 induce neurite outgrowth, and both activate the FGF 
receptor and associated downstream signalling pathways. Np65 binds to 
and colocalises with GABA(A) receptor subtypes (TC # 1.A.9) and may play a role in 
anchoring them to specific synaptic and extrasynaptic sites. The neuroplastins have been shown to chaperone and support the 
monocarboxylate transporter MCT2 in transporting lactate across the 
neuronal plasma membrane. The neuroplastins are multifunctional 
adhesins that support neurite outgrowth, modulate long-term 
activity-dependent synaptic plasticity, regulate surface expression of 
GluR1 receptors, modulate GABA(A) receptor localisation, and play a key 
role in delivery of monocarboxylate energy substrates both to the 
synapse and to extrasynaptic sites (<span id='ref34547012.25300133' class='cite'>Beesley <em>et al.</em> 2014</span>).&nbsp;</p>
<p>Viral entry into the host cell is the first step towards successful 
infection. Viral entry starts with virion attachment, and binding to 
receptors. Receptor binding viruses either directly release their 
genomes into the cell, or enter cells through endocytosis. For DNA 
viruses and a few RNA viruses, the endocytosed viruses is transported 
from cytoplasm into the nucleus followed by gene expression. The 
receptor for infection by white spot syndrome virus (WSSV) for kuruma 
shrimp, <em>Marsupenaeus japonicus</em>, is a member of the 
immunoglobulin superfamily (IgSF) with a transmembrane region, and is 
similar to the vertebrate polymeric immunoglobulin receptor (pIgR). 
MjpIgR was detected in all tissues tested, and its expression was 
induced by WSSV infection. Knockdown of MjpIgR, and blocking MjpIgR with
 its antibody inhibited WSSV infection, and overexpression facilitated 
the invasion. The extracellular domain of MjpIgR interacts with envelope
 protein VP24 of WSSV and the intracellular domain interacts with 
calmodulin (MjCaM). MjpIgR oligomerizes and is internalized by  
clathrin-dependent endocytosis (<span id='ref34549753.30726286' class='cite'>Niu <em>et al.</em> 2019</span>).</p>
<p>CD4 is an <span>integral membrane glycoprotein that plays an 
essential role in the immune response and serves multiple functions in 
responses to both external and internal stimuli. In T-cells,&nbsp; it
functions primarily as a coreceptor for MHC class II molecule:peptide 
complex (<span id='ref34551248.2823150' class='cite'>Doyle and Strominger 2006</span>). The antigens presented by class II peptides are derived from 
extracellular proteins while class I peptides are derived from cytosolic
 proteins. CD4 interacts simultaneously with the T-cell receptor (TCR) and 
the MHC class II presented by antigen-presenting cells (APCs) (<span id='ref34551249.16951326' class='cite'>Bernstein <em>et al.</em> 2006</span>). In turn, 
it recruits the Src kinase LCK to the vicinity of the TCR-CD3 complex. LCK 
then initiates different intracellular signaling pathways by 
phosphorylating various substrates, ultimately leading to lymphokine 
production, motility, adhesion and activation of T-helper cells. In 
other cells such as macrophages or NK cells, it plays a role in 
differentiation/activation, cytokine expression and cell migration in a 
TCR/LCK-independent pathway (<span id='ref34551250.24942581' class='cite'>Zhen <em>et al.</em> 2014</span>) while participating in the development of T-helper
 cells in the thymus and triggering the differentiation of monocytes into 
functional mature macrophages </span><span><span>(<a class='reflink' href='../../search/result.php?tc=9.B.385#ref34551250'>Zhen <em>et al.</em> 2014</a>)</span>.&nbsp; It is </span><span><span>the primary receptor for human immunodeficiency virus-1 (HIV-1) (<span id='ref34551251.2214026' class='cite'>Crise <em>et al.</em> 1990</span>, <span id='ref34551252.16331979' class='cite'>Sharma <em>et al.</em> 2005</span>, <span id='ref34551253.12089508' class='cite'>Matthias <em>et al.</em> 2002</span>). It is down-regulated by HIV-1 Vpu (<span id='ref34551254.17346169' class='cite'>Lindwasser <em>et al.</em> 2007</span>) and acts as a receptor for human Herpes virus 7/HHV-7 (<span id='ref34551255.7909607' class='cite'>Lusso <em>et al.</em> 1994</span>).
 CD4 and its co-receptor, CCR5, exist in the membrane in a fluid state 
that may be essential for membrane fusion between the viral envelop and 
the cell membrane (<span id='ref34551263.12089508' class='cite'>Matthias <em>et al.</em> 2002</span>). </span></span></p>
<p>Ephrin-B1 is one of the critical components of the slit diaphragm of kidney glomerular podocytes. Ephrin-B1-associated molecules were studied (<span id='ref34553685.33887216' class='cite'>Fukusumi <em>et al.</em> 2021</span>). Na<sup>+</sup>/H<sup>+</sup> exchanger regulatory factor 2 (NHERF2), a scaffolding protein, is associated with ephrin-B1. NHERF2 was expressed in the apical area and the slit diaphragm, and it interacted with the nephrin-ephrin-B1 complex at the slit diaphragm. The nephrin-ephrin-B1-NHERF2 complex interacted with ezrin bound to F-actin. NHERF2 bound ephrin-B1 via its first postsynaptic density protein-95/disks large/zonula occludens-1 domain, and podocalyxin via its second postsynaptic density protein-95/disks large/zonula occludens-1 domain. Phosphorylation of nephrin and ephrin-B1, and dephosphorylation of NHERF2 and ezrin, disrupted the linkages of ephrin-B1-NHERF2 and NHERF2-ezrin (<span id='ref34553685.33887216' class='cite'>Fukusumi <em>et al.</em> 2021</span>).</p>
<p>Interactions between the polysialylated neural cell adhesion molecule (TC# 8.A.23.1.49)
 and the transient receptor potential canonical channels TrpC1, 4, and 5 
induce entry of Ca<sup>2+</sup> into neurons (<span id='ref34555445.36077460' class='cite'>Amores-Bonet <em>et al.</em> 2022</span>). NCAMs play roles in the developing and mature nervous systems.&nbsp;<span id='ref34555445.36077460' class='cite'>Amores-Bonet <em>et al.</em> 2022</span> showed that the transient receptor potential canonical (TRPC) ion 
channels TRPC1, -4, and -5 not only interact with the intracellular 
domains of the transmembrane isoforms NCAM140 and NCAM180, but also with the glycan polysialic acid (PSA) covalently attached to the NCAM protein backbone. NCAM antibody treatment leads to the opening of TRPC1, -4, and -5 hetero- or homomers at the plasma membrane and to the influx of Ca<sup>2+</sup> into cultured cortical neurons and CHO cells expressing NCAM, PSA, and TRPC1 and -4 or TRPC1 and -5. NCAM-stimulated Ca<sup>2+</sup> entry was blocked by the TRPC inhibitor Pico145 or the bacterial PSA homolog colominic acid. NCAM-stimulated Ca<sup>2+</sup> influx was detectable neither in NCAM-deficient cortical neurons nor in TRPC1/4- or TRPC1/5-expressing CHO cells that express NCAM, but not PSA. NCAM-induced neurite outgrowth was reduced by TRPC inhibitors and a function-blocking TRPC1 antibody. A characteristic signaling feature was that extracellular signal-regulated kinase 1/2 phosphorylation was also reduced by TRPC inhibitors. This indicates that the interaction of NCAM with TRPC1, -4, and -5 contributes to the NCAM-stimulated and PSA-dependent Ca<sup>2+</sup> entry into neurons, thereby influencing essential neural functions (<span id='ref34555445.36077460' class='cite'>Amores-Bonet <em>et al.</em> 2022</span>).</p>
<p>&nbsp;</p>
<p>&nbsp;</p><BR></TD></TR><TR><TD COLSPAN=5><HR>This family belongs to the <A HREF="superfamily.php?id=127">Basigin-Tapasin-TREM2/PIGR Superfamily</A>.<BR><HR></TD></TR><TR><TD COLSPAN=5><a name="references"></a>&nbsp;<p><B>References:</B><P></TD></TR><TR><TD COLSPAN=5>Al-Akhrass, H., J.R.W. Conway, A.S.A. Poulsen, I. Paatero, J. Kaivola, A. Padzik, O.M. Andersen, and J. Ivaska. (2021).  A feed-forward loop between SorLA and HER3 determines heregulin response and neratinib resistance.  Oncogene 40: 1300-1317.<BR><HR></TD></TR><TR><TD COLSPAN=5>Amores-Bonet, L., R. Kleene, T. Theis, and M. Schachner. (2022).  Interactions between the Polysialylated Neural Cell Adhesion Molecule and the Transient Receptor Potential Canonical Channels 1, 4, and 5 Induce Entry of Ca into Neuron.s.  Int J Mol Sci 23:.<BR><HR></TD></TR><TR><TD COLSPAN=5>An, B., A. Ando, H. Akuta, F. Morishita, and T. Imamura. (2023).  Human-biased TMEM25 expression promotes expansion of neural progenitor cells to alter cortical structure in the developing brain.  FEBS Lett. [Epub:  Ahead of Print]<BR><HR></TD></TR><TR><TD COLSPAN=5>Anfosso, F., N. Bardin, E. Vivier, F. Sabatier, J. Sampol, and F. Dignat-George. (2001).  Outside-in signaling pathway linked to CD146 engagement in human endothelial cells.  J. Biol. Chem. 276: 1564-1569.<BR><HR></TD></TR><TR><TD COLSPAN=5>Bailly, C., X. Thuru, and B. Quesnel. (2021).  Soluble Programmed Death Ligand-1 (sPD-L1): A Pool of Circulating Proteins Implicated in Health and Diseases.  Cancers (Basel) 13:.<BR><HR></TD></TR><TR><TD COLSPAN=5>Bartoszewski, S., S. Luschnig, I. Desjeux, J. Grosshans, and C. Nüsslein-Volhard. (2004).  <i>Drosophila</i> p24 homologues eclair and baiser are necessary for the activity of the maternally expressed Tkv receptor during early embryogenesis.  Mech Dev 121: 1259-1273.<BR><HR></TD></TR><TR><TD COLSPAN=5>Beesley, P., M. Kraus, and N. Parolaro. (2014).  The neuroplastins: multifunctional neuronal adhesion molecules--involvement in behaviour and disease.  Adv Neurobiol 8: 61-89.<BR><HR></TD></TR><TR><TD COLSPAN=5>Ben Mkaddem, S., M. Aloulou, M. Benhamou, and R.C. Monteiro. (2014).  Role of FcγRIIIA (CD16) in IVIg-mediated anti-inflammatory function.  J Clin Immunol 34Suppl1: S46-50.<BR><HR></TD></TR><TR><TD COLSPAN=5>Bernstein, H.B., M.C. Plasterer, S.E. Schiff, C.M. Kitchen, S. Kitchen, and J.A. Zack. (2006).  CD4 expression on activated NK cells: ligation of CD4 induces cytokine expression and cell migration.  J Immunol 177: 3669-3676.<BR><HR></TD></TR><TR><TD COLSPAN=5>Bi, J., Z. Wu, X. Zhang, T. Zeng, W. Dai, N. Qiu, M. Xu, Y. Qiao, L. Ke, J. Zhao, X. Cao, Q. Lin, X.L. Chen, L. Xie, Z. Ouyang, J. Guo, L. Zheng, C. Ma, S. Guo, K. Chen, W. Mo, G. Fu, T.J. Zhao, and H.R. Wang. (2023).  TMEM25 inhibits monomeric EGFR-mediated STAT3 activation in basal state to suppress triple-negative breast cancer progression.  Nat Commun 14: 2342.<BR><HR></TD></TR><TR><TD COLSPAN=5>Burr, M.L., C.E. Sparbier, Y.C. Chan, J.C. Williamson, K. Woods, P.A. Beavis, E.Y.N. Lam, M.A. Henderson, C.C. Bell, S. Stolzenburg, O. Gilan, S. Bloor, T. Noori, D.W. Morgens, M.C. Bassik, P.J. Neeson, A. Behren, P.K. Darcy, S.J. Dawson, I. Voskoboinik, J.A. Trapani, J. Cebon, P.J. Lehner, and M.A. Dawson. (2017).  CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity.  Nature 549: 101-105.<BR><HR></TD></TR><TR><TD COLSPAN=5>Cai, K., X. Zhang, and X.C. Bai. (2022).  Cryo-electron Microscopic Analysis of Single-Pass Transmembrane Receptors.  Chem Rev. [Epub:  Ahead of Print]<BR><HR></TD></TR><TR><TD COLSPAN=5>Capdevila-Nortes X., Jeworutzki E., Elorza-Vidal X., Barrallo-Gimeno A., Pusch M. and Estevez R. (2015). Structural determinants of interaction, trafficking and function in the ClC-2/MLC1 subunit GlialCAM involved in leukodystrophy. J Physiol. 593(18):4165-80.<BR><HR></TD></TR><TR><TD COLSPAN=5>Chang, X., Y.H. Song, T. Xia, Z.X. He, S.B. Zhao, Z.J. Wang, L. Gu, Z.S. Li, C. Xu, S.L. Wang, and Y. Bai. (2023).  Macrophage-derived exosomes promote intestinal mucosal barrier dysfunction in inflammatory bowel disease by regulating TMIGD1 via mircroRNA-223.  Int Immunopharmacol 121: 110447. [Epub:  Ahead of Print]<BR><HR></TD></TR><TR><TD COLSPAN=5>Chen, D., P.W. Li, B.A. Goldstein, W. Cai, E.L. Thomas, F. Chen, A.E. Hubbard, S. Melov, and P. Kapahi. (2013).  Germline signaling mediates the synergistically prolonged longevity produced by double mutations in daf-2 and rsks-1 in <i>C. elegans</i>.  Cell Rep 5: 1600-1610.<BR><HR></TD></TR><TR><TD COLSPAN=5>Cho, H.J., J. Yu, C. Xie, P. Rudrabhatla, X. Chen, J. Wu, L. Parisiadou, G. Liu, L. Sun, B. Ma, J. Ding, Z. Liu, and H. Cai. (2014).  Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export.  EMBO. J. 33: 2314-2331.<BR><HR></TD></TR><TR><TD COLSPAN=5>Cohen, C.J., J.T. Shieh, R.J. Pickles, T. Okegawa, J.T. Hsieh, and J.M. Bergelson. (2001).  The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction.  Proc. Natl. Acad. Sci. USA 98: 15191-15196.<BR><HR></TD></TR><TR><TD COLSPAN=5>Crise, B., L. Buonocore, and J.K. Rose. (1990).  CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor.  J. Virol. 64: 5585-5593.<BR><HR></TD></TR><TR><TD COLSPAN=5>Dascalu, A.E., C. Furman, I. Landrieu, F.X. Cantrelle, J. Mortelecque, G. Grolaux, P. Gillery, F. Tessier, E. Lipka, M. Billamboz, E. Boulanger, and A. Ghinet. (2024).  Development of Receptor for Advanced Glycation End Products (RAGE) ligands through target directed dynamic combinatorial chemistry: a novel class of possible antagonists.  Chemistry 30: e202303255.<BR><HR></TD></TR><TR><TD COLSPAN=5>Dietrich, J., M. Cella, M. Seiffert, H.J. Bühring, and M. Colonna. (2000).  Cutting edge: signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells.  J Immunol 164: 9-12.<BR><HR></TD></TR><TR><TD COLSPAN=5>Doyle, C. and J.L. Strominger. (2006).  Interaction between CD4 and class II MHC molecules mediates cell adhesion.  Nature 330: 256-259.<BR><HR></TD></TR><TR><TD COLSPAN=5>Erber, R., U. Eichelsbacher, V. Powajbo, T. Korn, V. Djonov, J. Lin, H.P. Hammes, R. Grobholz, A. Ullrich, and P. Vajkoczy. (2006).  EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.  EMBO. J. 25: 628-641.<BR><HR></TD></TR><TR><TD COLSPAN=5>Fang, F., L.F. Lue, S. Yan, H. Xu, J.S. Luddy, D. Chen, D.G. Walker, D.M. Stern, S. Yan, A.M. Schmidt, J.X. Chen, and S.S. Yan. (2010).  RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer''s disease.  FASEB J. 24: 1043-1055.<BR><HR></TD></TR><TR><TD COLSPAN=5>Ferrara, C., S. Grau, C. Jäger, P. Sondermann, P. Brünker, I. Waldhauer, M. Hennig, A. Ruf, A.C. Rufer, M. Stihle, P. Umaña, and J. Benz. (2011).  Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose.  Proc. Natl. Acad. Sci. USA 108: 12669-12674.<BR><HR></TD></TR><TR><TD COLSPAN=5>Fierro-González, J.C., M. González-Barrios, A. Miranda-Vizuete, and P. Swoboda. (2011).  The thioredoxin TRX-1 regulates adult lifespan extension induced by dietary restriction in <i>Caenorhabditis elegans</i>.  Biochem. Biophys. Res. Commun. 406: 478-482.<BR><HR></TD></TR><TR><TD COLSPAN=5>Freeman, G.J., A.J. Long, Y. Iwai, K. Bourque, T. Chernova, H. Nishimura, L.J. Fitz, N. Malenkovich, T. Okazaki, M.C. Byrne, H.F. Horton, L. Fouser, L. Carter, V. Ling, M.R. Bowman, B.M. Carreno, M. Collins, C.R. Wood, and T. Honjo. (2000).  Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.  J Exp Med 192: 1027-1034.<BR><HR></TD></TR><TR><TD COLSPAN=5>Fukusumi, Y., H. Yasuda, Y. Zhang, and H. Kawachi. (2021).  Nephrin-Ephrin-B1-Na/H Exchanger Regulatory Factor 2-Ezrin-Actin Axis Is Critical in Podocyte Injury.  Am J Pathol 191: 1209-1226.<BR><HR></TD></TR><TR><TD COLSPAN=5>Gao, Y., D. Zhang, F. Wang, D. Zhang, P. Li, and K. Wang. (2022).  BRAF V600E protect from cell death via inhibition of the mitochondrial permeability transition in papillary and anaplastic thyroid cancers.  J Cell Mol Med 26: 4048-4060.<BR><HR></TD></TR><TR><TD COLSPAN=5>Geiger, J.A., L. Carvalho, I. Campos, A.C. Santos, and A. Jacinto. (2011).  Hole-in-one mutant phenotypes link EGFR/ERK signaling to epithelial tissue repair in <i>Drosophila</i>.  PLoS One 6: e28349.<BR><HR></TD></TR><TR><TD COLSPAN=5>Giepmans, B.N. (2006).  Role of connexin43-interacting proteins at gap junctions.  Adv Cardiol 42: 41-56.<BR><HR></TD></TR><TR><TD COLSPAN=5>Gómez-Suaga, P., B. Luzón-Toro, D. Churamani, L. Zhang, D. Bloor-Young, S. Patel, P.G. Woodman, G.C. Churchill, and S. Hilfiker. (2012).  Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP.  Hum Mol Genet 21: 511-525.<BR><HR></TD></TR><TR><TD COLSPAN=5>González-Cabrero, J., C.J. Wise, Y. Latchman, G.J. Freeman, A.H. Sharpe, and H. Reiser. (1999).  CD48-deficient mice have a pronounced defect in CD4(+) T cell activation.  Proc. Natl. Acad. Sci. USA 96: 1019-1023.<BR><HR></TD></TR><TR><TD COLSPAN=5>Griewank, K., C. Borowski, S. Rietdijk, N. Wang, A. Julien, D.G. Wei, A.A. Mamchak, C. Terhorst, and A. Bendelac. (2007).  Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development.  Immunity 27: 751-762.<BR><HR></TD></TR><TR><TD COLSPAN=5>Griffin, J.H., J. Leung, R.J. Bruner, M.A. Caligiuri, and R. Briesewitz. (2003).  Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome.  Proc. Natl. Acad. Sci. USA 100: 7830-7835.<BR><HR></TD></TR><TR><TD COLSPAN=5>Guo, L., D.R. Bertola, A. Takanohashi, A. Saito, Y. Segawa, T. Yokota, S. Ishibashi, Y. Nishida, G.L. Yamamoto, J.F.D.S. Franco, R.S. Honjo, C.A. Kim, C.M. Musso, M. Timmons, A. Pizzino, R.J. Taft, B. Lajoie, M.A. Knight, K.H. Fischbeck, A.B. Singleton, C.R. Ferreira, Z. Wang, L. Yan, J.Y. Garbern, P.O. Simsek-Kiper, H. Ohashi, P.G. Robey, A. Boyde, N. Matsumoto, N. Miyake, J. Spranger, R. Schiffmann, A. Vanderver, G. Nishimura, M.R.D.S. Passos-Bueno, C. Simons, K. Ishikawa, and S. Ikegawa. (2019).  Bi-allelic CSF1R Mutations Cause Skeletal Dysplasia of Dysosteosclerosis-Pyle Disease Spectrum and Degenerative Encephalopathy with Brain Malformation.  Am J Hum Genet 104: 925-935.<BR><HR></TD></TR><TR><TD COLSPAN=5>Haenzi, B. and L.D. Moon. (2017).  The Function of FGFR1 Signalling in the Spinal Cord: Therapeutic Approaches Using FGFR1 Ligands after Spinal Cord Injury.  Neural Plast 2017: 2740768.<BR><HR></TD></TR><TR><TD COLSPAN=5>Halestrap, A.P. (2012).  The monocarboxylate transporter family--Structure and functional characterization.  IUBMB Life 64: 1-9.<BR><HR></TD></TR><TR><TD COLSPAN=5>Halestrap, A.P. (2013).  The SLC16 gene family - structure, role and regulation in health and disease.  Mol Aspects Med 34: 337-349.<BR><HR></TD></TR><TR><TD COLSPAN=5>Haniu, M., J. Talvenheimo, J. Le, V. Katta, A. Welcher, and M.F. Rohde. (1995).  Extracellular domain of neurotrophin receptor trkB: disulfide structure, N-glycosylation sites, and ligand binding.  Arch Biochem Biophys 322: 256-264.<BR><HR></TD></TR><TR><TD COLSPAN=5>Hayashi, A., H. Ohnishi, H. Okazawa, S. Nakazawa, H. Ikeda, S. Motegi, N. Aoki, S. Kimura, M. Mikuni, and T. Matozaki. (2004).  Positive regulation of phagocytosis by SIRPbeta and its signaling mechanism in macrophages.  J. Biol. Chem. 279: 29450-29460.<BR><HR></TD></TR><TR><TD COLSPAN=5>Hayashi, T., T. Takahashi, S. Motoya, T. Ishida, F. Itoh, M. Adachi, Y. Hinoda, and K. Imai. (2001).  MUC1 mucin core protein binds to the domain 1 of ICAM-1.  Digestion 63Suppl1: 87-92.<BR><HR></TD></TR><TR><TD COLSPAN=5>Hoorn, E.J. and J.H.F. de Baaij. (2022).  Chloride-sensitive signaling turns the potassium switch on.  Kidney Int 102: 956-958.<BR><HR></TD></TR><TR><TD COLSPAN=5>Hu, M.C., M. Shi, and O.W. Moe. (2018).  Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters.  Pflugers Arch. [Epub:  Ahead of Print]<BR><HR></TD></TR><TR><TD COLSPAN=5>Huang, Y.A., B. Zhou, M. Wernig, and T.C. Südhof. (2017).  ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion.  Cell 168: 427-441.e21.<BR><HR></TD></TR><TR><TD COLSPAN=5>Ieguchi, K., M. Fujita, Z. Ma, P. Davari, Y. Taniguchi, K. Sekiguchi, B. Wang, Y.K. Takada, and Y. Takada. (2010).  Direct binding of the EGF-like domain of neuregulin-1 to integrins ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB signaling.  J. Biol. Chem. 285: 31388-31398.<BR><HR></TD></TR><TR><TD COLSPAN=5>Ifie, E., M.A. Russell, S. Dhayal, P. Leete, G. Sebastiani, L. Nigi, F. Dotta, V. Marjomäki, D.L. Eizirik, N.G. Morgan, and S.J. Richardson. (2018).  Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells.  Diabetologia. [Epub:  Ahead of Print]<BR><HR></TD></TR><TR><TD COLSPAN=5>Irmer, B., J. Efing, L.E. Reitnauer, A. Angenendt, S. Heinrichs, A. Schubert, M. Schulz, C. Binder, J. Tio, U. Hansen, C. Geyer, M. Gerwing, A. Bleckmann, and K. Menck. (2023).  Extracellular vesicle-associated tyrosine kinase-like orphan receptors ROR1 and ROR2 promote breast cancer progression.  Cell Commun Signal 21: 171.<BR><HR></TD></TR><TR><TD COLSPAN=5>Jiang, H., X. Zhang, Y. Wu, B. Zhang, J. Wei, J. Li, Y. Huang, L. Chen, and X. He. (2022).  Bioinformatics identification and validation of biomarkers and infiltrating immune cells in endometriosis.  Front Immunol 13: 944683.<BR><HR></TD></TR><TR><TD COLSPAN=5>Jin, Q., H. Chen, A. Luo, F. Ding, and Z. Liu. (2011).  S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE).  PLoS One 6: e19375.<BR><HR></TD></TR><TR><TD COLSPAN=5>Johnson, J.P., U. Rothbächer, and C. Sers. (1993).  The progression associated antigen MUC18: a unique member of the immunoglobulin supergene family.  Melanoma Res 3: 337-340.<BR><HR></TD></TR><TR><TD COLSPAN=5>Kamakura, S., J. Hayase, A. Kohda, Y. Iwakiri, K. Chishiki, T. Izaki, and H. Sumimoto. (2024).  TMEM25 is a Par3-binding protein that attenuates claudin assembly during tight junction development.  EMBO Rep 25: 144-167.<BR><HR></TD></TR><TR><TD COLSPAN=5>Kanekura, T. (2023).  CD147/Basigin Is Involved in the Development of Malignant Tumors and T-Cell-Mediated Immunological Disorders via Regulation of Glycolysis.  Int J Mol Sci 24:.<BR><HR></TD></TR><TR><TD COLSPAN=5>Kazlauskas, A., D.L. Durden, and J.A. Cooper. (1991).  Functions of the major tyrosine phosphorylation site of the PDGF receptor beta subunit.  Cell Regul 2: 413-425.<BR><HR></TD></TR><TR><TD COLSPAN=5>Kelly, J.D., B.A. Haldeman, F.J. Grant, M.J. Murray, R.A. Seifert, D.F. Bowen-Pope, J.A. Cooper, and A. Kazlauskas. (1991).  Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit <i>trans</i>-phosphorylation.  J. Biol. Chem. 266: 8987-8992.<BR><HR></TD></TR><TR><TD COLSPAN=5>Kendrick, A.A., J. Schafer, M. Dzieciatkowska, T. Nemkov, A.D. Alessandro, D. Neelakantan, H.L. Ford, C.G. Pearson, C.D. Weekes, K.C. Hansen, and E.Z. Eisenmesser. (2016).  CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming.  Oncotarget. [Epub:  Ahead of Print]<BR><HR></TD></TR><TR><TD COLSPAN=5>King, N.R., C. Martins Freire, J. Touhami, M. Sitbon, A.M. Toye, and T.J. Satchwell. (2024).  Basigin mediation of  <i>Plasmodium falciparum</i> red blood cell invasion does not require its transmembrane domain or interaction with monocarboxylate transporter 1.  PLoS Pathog 20: e1011989. [Epub:  Ahead of Print]<BR><HR></TD></TR><TR><TD COLSPAN=5>Köpnick, A.L., A. Jansen, K. Geistlinger, N.H. Epalle, and E. Beitz. (2021).  Basigin drives intracellular accumulation of l-lactate by harvesting protons and substrate anions.  PLoS One 16: e0249110.<BR><HR></TD></TR><TR><TD COLSPAN=5>Koppel, N., M.B. Friese, H.L. Cardasis, T.A. Neubert, and S.J. Burden. (2019).  Vezatin is required for the maturation of the neuromuscular synapse.  Mol. Biol. Cell 30: 2571-2583.<BR><HR></TD></TR><TR><TD COLSPAN=5>Lehman, S.L., G.J. Cerniglia, G.J. Johannes, J. Ye, S. Ryeom, and C. Koumenis. (2015).  Translational Upregulation of an Individual p21Cip1 Transcript Variant by GCN2 Regulates Cell Proliferation and Survival under Nutrient Stress.  PLoS Genet 11: e1005212.<BR><HR></TD></TR><TR><TD COLSPAN=5>Li, H., L. Yang, Y. Sun, Y. Zhang, J. Chai, B. Liu, and Y. Ye. (2021).  Silencing of CD147 inhibits hepatic stellate cells activation related to suppressing aerobic glycolysis via hedgehog signaling.  Cytotechnology 73: 233-242.<BR><HR></TD></TR><TR><TD COLSPAN=5>Li, K., Q. Li, S.T. Bashir, B.M. Bany, and R.A. Nowak. (2021).  Loss of Basigin expression in uterine cells leads to subfertility in female mice.  Biol Reprod. [Epub:  Ahead of Print]<BR><HR></TD></TR><TR><TD COLSPAN=5>Li, Y., J. Zhang, Y. Cai, H. Liu, W. Yang, Y. Xu, and M. Huang. (2023).  VSTM2L contributes to anoikis resistance and acts as a novel biomarker for metastasis and clinical outcome in ovarian cancer.  Biochem. Biophys. Res. Commun. 658: 107-115.<BR><HR></TD></TR><TR><TD COLSPAN=5>Lin, X., M.G.K. Brunk, P. Yuanxiang, A.W. Curran, E. Zhang, F. Stöber, J. Goldschmidt, E.D. Gundelfinger, M. Vollmer, M.F.K. Happel, R. Herrera-Molina, and D. Montag. (2021).  Neuroplastin expression is essential for hearing and hair cell PMCA expression.  Brain Struct Funct 226: 1533-1551.<BR><HR></TD></TR><TR><TD COLSPAN=5>Lindwasser, O.W., R. Chaudhuri, and J.S. Bonifacino. (2007).  Mechanisms of CD4 downregulation by the Nef and Vpu proteins of primate immunodeficiency viruses.  Curr Mol Med 7: 171-184.<BR><HR></TD></TR><TR><TD COLSPAN=5>Loers, G., R. Kleene, V. Granato, U. Bork, and M. Schachner. (2023).  Interaction of L1CAM with LC3 Is Required for L1-Dependent Neurite Outgrowth and Neuron.al Survival.  Int J Mol Sci 24:.<BR><HR></TD></TR><TR><TD COLSPAN=5>Luo, Z., W. Zeng, W. Tang, T. Long, J. Zhang, X. Xie, Y. Kuang, M. Chen, J. Su, and X. Chen. (2014).  CD147 interacts with NDUFS6 in regulating mitochondrial complex I activity and the mitochondrial apoptotic pathway in human malignant melanoma cells.  Curr Mol Med 14: 1252-1264.<BR><HR></TD></TR><TR><TD COLSPAN=5>Lusso, P., P. Secchiero, R.W. Crowley, A. Garzino-Demo, Z.N. Berneman, and R.C. Gallo. (1994).  CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus.  Proc. Natl. Acad. Sci. USA 91: 3872-3876.<BR><HR></TD></TR><TR><TD COLSPAN=5>Lv, J., W. Ge, Z. Ding, J. Zeng, W. Wang, H. Duan, Y. Zhang, X. Zhao, and J. Hu. (2022).  Regulatory role of dihydrotestosterone on BMP-6 receptors in granular cells of sheep antral follicles.  Gene 810: 146066.<BR><HR></TD></TR><TR><TD COLSPAN=5>Martin, T.M., S.J. Burke, C.H. Wasserfall, and J.J. Collier. (2023).  Islet β-cells and intercellular adhesion molecule-1 (ICAM-1): Integrating immune responses that influence autoimmunity and graft rejection.  Autoimmun Rev 22: 103414. [Epub:  Ahead of Print]<BR><HR></TD></TR><TR><TD COLSPAN=5>Martin-Almedina, S., I. Martinez-Corral, R. Holdhus, A. Vicente, E. Fotiou, S. Lin, K. Petersen, M.A. Simpson, A. Hoischen, C. Gilissen, H. Jeffery, G. Atton, C. Karapouliou, G. Brice, K. Gordon, J.W. Wiseman, M. Wedin, S.G. Rockson, S. Jeffery, P.S. Mortimer, M.P. Snyder, S. Berland, S. Mansour, T. Makinen, and P. Ostergaard. (2016).  EPHB4 kinase-inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis.  J Clin Invest 126: 3080-3088.<BR><HR></TD></TR><TR><TD COLSPAN=5>Martinez, B.A., P. Reis Rodrigues, R.M. Nuñez Medina, P. Mondal, N.J. Harrison, M.A. Lone, A. Webster, A.U. Gurkar, B. Grill, and M.S. Gill. (2020).  An alternatively spliced, non-signaling insulin receptor modulates insulin sensitivity via insulin peptide sequestration in.  Elife 9:.<BR><HR></TD></TR><TR><TD COLSPAN=5>Matthias, L.J., P.T. Yam, X.M. Jiang, N. Vandegraaff, P. Li, P. Poumbourios, N. Donoghue, and P.J. Hogg. (2002).  Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1.  Nat Immunol 3: 727-732.<BR><HR></TD></TR><TR><TD COLSPAN=5>Mezzadra, R., C. Sun, L.T. Jae, R. Gomez-Eerland, E. de Vries, W. Wu, M.E.W. Logtenberg, M. Slagter, E.A. Rozeman, I. Hofland, A. Broeks, H.M. Horlings, L.F.A. Wessels, C.U. Blank, Y. Xiao, A.J.R. Heck, J. Borst, T.R. Brummelkamp, and T.N.M. Schumacher. (2017).  Identification of CMTM6 and CMTM4 as PD-L1 protein regulators.  Nature 549: 106-110.<BR><HR></TD></TR><TR><TD COLSPAN=5>Mizushima, T., H. Yagi, E. Takemoto, M. Shibata-Koyama, Y. Isoda, S. Iida, K. Masuda, M. Satoh, and K. Kato. (2011).  Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans.  Genes Cells 16: 1071-1080.<BR><HR></TD></TR><TR><TD COLSPAN=5>Moreau, F., N.S. Kirk, F. Zhang, V. Gelfanov, E.O. List, M. Chrudinová, H. Venugopal, M.C. Lawrence, V. Jimenez, F. Bosch, J.J. Kopchick, R.D. DiMarchi, E. Altindis, and C. Ronald Kahn. (2022).  Interaction of a viral insulin-like peptide with the IGF-1 receptor produces a natural antagonist.  Nat Commun 13: 6700.<BR><HR></TD></TR><TR><TD COLSPAN=5>Mu, L., Y. Wang, Y. Hu, C. Shi, B.A. Alman, C. Zhang, and J. She. (2022).  The Role of TMIGD1 as a Tumor Suppressor in Colorectal Cancer.  Genet Test Mol Biomarkers 26: 174-183.<BR><HR></TD></TR><TR><TD COLSPAN=5>Mulukala, S.K.N., S.S. Irukuvajjula, K. Kumar, K. Garai, P. Venkatesu, R. Vadrevu, and A.K. Pasupulati. (2020).  Structural features and oligomeric nature of human podocin domain.  Biochem Biophys Rep 23: 100774.<BR><HR></TD></TR><TR><TD COLSPAN=5>Muramatsu, T. (2016).  Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners.  J Biochem 159: 481-490.<BR><HR></TD></TR><TR><TD COLSPAN=5>Niu, G.J., S. Wang, J.D. Xu, M.C. Yang, J.J. Sun, Z.H. He, X.F. Zhao, and J.X. Wang. (2019).  The polymeric immunoglobulin receptor-like protein from Marsupenaeus japonicus is a receptor for white spot syndrome virus infection.  PLoS Pathog 15: e1007558.<BR><HR></TD></TR><TR><TD COLSPAN=5>Nyalali, A.M.K., A.U. Leonard, Y. Xu, H. Li, J. Zhou, X. Zhang, T.K. Rugambwa, X. Shi, and F. Li. (2023).  CD147: an integral and potential molecule to abrogate hallmarks of cancer.  Front Oncol 13: 1238051.<BR><HR></TD></TR><TR><TD COLSPAN=5>Ovens, M.J., C. Manoharan, M.C. Wilson, C.M. Murray, and A.P. Halestrap. (2010).  The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein.  Biochem. J. 431: 217-225.<BR><HR></TD></TR><TR><TD COLSPAN=5>Park, E.S., S.M. Jeon, H. Weon, H.J. Cho, and D.H. Youn. (2017).  Activated leukocyte cell adhesion molecule is involved in excitatory synaptic transmission and plasticity in the rat spinal dorsal horn.  Neurosci Lett 656: 9-14.<BR><HR></TD></TR><TR><TD COLSPAN=5>Park, H., F.G. Adsit, and J.C. Boyington. (2010).  The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding.  J. Biol. Chem. 285: 40762-40770.<BR><HR></TD></TR><TR><TD COLSPAN=5>Pu, X., L. Li, Z. Chen, A. Gong, J. Lei, L. Zhang, and H.I. Tsai. (2023).  PERK/ATF3-Reduced ER Stress on high potassium environment in the suppression of tumor ferroptosis.  J Cancer 14: 1336-1349.<BR><HR></TD></TR><TR><TD COLSPAN=5>Ramirez, R., A. Martin-Malo, and P. Aljama. (2007).  Inflammation and hemodiafiltration.  Contrib Nephrol 158: 210-215.<BR><HR></TD></TR><TR><TD COLSPAN=5>Raphael, I., R.R. Joern, and T.G. Forsthuber. (2020).  Memory CD4 T Cells in Immunity and Autoimmune Diseases.  Cells 9:.<BR><HR></TD></TR><TR><TD COLSPAN=5>Rathjen, F.G. (2020).  The CAR group of Ig cell adhesion proteins-Regulators of gap junctions?  Bioessays 42: e2000031.<BR><HR></TD></TR><TR><TD COLSPAN=5>Runkle, K.B., A. Kharbanda, E. Stypulkowski, X.J. Cao, W. Wang, B.A. Garcia, and E.S. Witze. (2016).  Inhibition of DHHC20-Mediated EGFR Palmitoylation Creates a Dependence on EGFR Signaling.  Mol. Cell 62: 385-396.<BR><HR></TD></TR><TR><TD COLSPAN=5>Rupar, K., M.S. Isidor, L. Argemi-Muntadas, M. Agueda-Oyarzabal, K. Plucińska, E.L. Brown, M. Mattanovich, S. Bossi, M. Tozzi, D. Tandio, P.S.S. Petersen, T.I. Henriksen, K. Trošt, J.B. Hansen, Z. Gerhart-Hines, S. Nielsen, T. Moritz, and B. Emanuelli. (2023).  Full activation of thermogenesis in brown adipocytes requires Basigin action.  FEBS J. 290: 2673-2691.<BR><HR></TD></TR><TR><TD COLSPAN=5>Schäfer, M.K., Y.C. Nam, A. Moumen, L. Keglowich, E. Bouché, M. Küffner, H.H. Bock, F.G. Rathjen, C. Raoul, and M. Frotscher. (2010).  L1 syndrome mutations impair neuronal L1 function at different levels by divergent mechanisms.  Neurobiol Dis 40: 222-237.<BR><HR></TD></TR><TR><TD COLSPAN=5>Sharma, D., M.M. Balamurali, K. Chakraborty, S. Kumaran, S. Jeganathan, U. Rashid, P. Ingallinella, and R. Varadarajan. (2005).  Protein minimization of the gp120 binding region of human CD4.  Biochemistry 44: 16192-16202.<BR><HR></TD></TR><TR><TD COLSPAN=5>Sippel, C.J., F.J. Suchy, M. Ananthanarayanan, and D.H. Perlmutter. (1993).  The rat liver ecto-ATPase is also a canalicular bile acid transport protein.  J. Biol. Chem. 268: 2083-2091.<BR><HR></TD></TR><TR><TD COLSPAN=5>Sippel, C.J., M.J. McCollum, and D.H. Perlmutter. (1994).  Bile acid transport by the rat liver canalicular bile acid transport/ecto-ATPase protein is dependent on ATP but not on its own ecto-ATPase activity.  J. Biol. Chem. 269: 2820-2826.<BR><HR></TD></TR><TR><TD COLSPAN=5>Slack, J.L., K. Schooley, T.P. Bonnert, J.L. Mitcham, E.E. Qwarnstrom, J.E. Sims, and S.K. Dower. (2000).  Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways.  J. Biol. Chem. 275: 4670-4678.<BR><HR></TD></TR><TR><TD COLSPAN=5>Smith, E.R., S.G. Holt, and T.D. Hewitson. (2017).  FGF23 activates injury-primed renal fibroblasts via FGFR4-dependent signalling and enhancement of TGF-β autoinduction.  Int J Biochem. Cell Biol. 92: 63-78.<BR><HR></TD></TR><TR><TD COLSPAN=5>Son, S.M., J. Yun, D.W. Kim, Y.S. Jung, S.B. Han, Y.H. Lee, H.S. Han, C.G. Woo, H.C. Lee, and O.J. Lee. (2023).  MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma.  BMC Cancer 23: 843.<BR><HR></TD></TR><TR><TD COLSPAN=5>Steinberg, F., S.D. Gerber, T. Rieckmann, and B. Trueb. (2010).  Rapid fusion and syncytium formation of heterologous cells upon expression of the FGFRL1 receptor.  J. Biol. Chem. 285: 37704-37715.<BR><HR></TD></TR><TR><TD COLSPAN=5>Stogmann, E., E. Reinthaler, S. Eltawil, M.A. El Etribi, M. Hemeda, N. El Nahhas, A.M. Gaber, A. Fouad, S. Edris, A. Benet-Pages, S.H. Eck, E. Pataraia, D. Mei, A. Brice, S. Lesage, R. Guerrini, F. Zimprich, T.M. Strom, and A. Zimprich. (2013).  Autosomal recessive cortical myoclonic tremor and epilepsy: association with a mutation in the potassium channel associated gene CNTN2.  Brain 136: 1155-1160.<BR><HR></TD></TR><TR><TD COLSPAN=5>Suchy, F.J., C.J. Sippel, and M. Ananthanarayanan. (1997).  Bile acid transport across the hepatocyte canalicular membrane.  FASEB J. 11: 199-205.<BR><HR></TD></TR><TR><TD COLSPAN=5>Suzuki, J., E. Imanishi, and S. Nagata. (2016).  Xkr8 phospholipid scrambling complex in apoptotic phosphatidylserine exposure.  Proc. Natl. Acad. Sci. USA 113: 9509-9514.<BR><HR></TD></TR><TR><TD COLSPAN=5>Tan-Sindhunata, M.B., I.B. Mathijssen, M. Smit, F. Baas, J.I. de Vries, J.P. van der Voorn, I. Kluijt, M.A. Hagen, E.W. Blom, E. Sistermans, H. Meijers-Heijboer, Q. Waisfisz, M.M. Weiss, and A.J. Groffen. (2015).  Identification of a Dutch founder mutation in MUSK causing fetal akinesia deformation sequence.  Eur J Hum Genet 23: 1151-1157.<BR><HR></TD></TR><TR><TD COLSPAN=5>Thüring, E.M., C. Hartmann, Y.A. Schwietzer, and K. Ebnet. (2023).  TMIGD1: Emerging functions of a tumor supressor and adhesion receptor.  Oncogene 42: 1777-1785.<BR><HR></TD></TR><TR><TD COLSPAN=5>Tiku, V., C. Jain, Y. Raz, S. Nakamura, B. Heestand, W. Liu, M. Späth, H.E.D. Suchiman, R.U. Müller, P.E. Slagboom, L. Partridge, and A. Antebi. (2017).  Small nucleoli are a cellular hallmark of longevity.  Nat Commun 8: 16083.<BR><HR></TD></TR><TR><TD COLSPAN=5>Togni, M., J. Lindquist, A. Gerber, U. Kölsch, A. Hamm-Baarke, S. Kliche, and B. Schraven. (2004).  The role of adaptor proteins in lymphocyte activation.  Mol Immunol 41: 615-630.<BR><HR></TD></TR><TR><TD COLSPAN=5>van Buul, J.D., M.J. Allingham, T. Samson, J. Meller, E. Boulter, R. García-Mata, and K. Burridge. (2007).  RhoG regulates endothelial apical cup assembly downstream from ICAM1 engagement and is involved in leukocyte <i>trans</i>-endothelial migration.  J. Cell Biol. 178: 1279-1293.<BR><HR></TD></TR><TR><TD COLSPAN=5>Vanlandewijck, M., T. Lebouvier, M. Andaloussi Mäe, K. Nahar, S. Hornemann, D. Kenkel, S.I. Cunha, J. Lennartsson, A. Boss, C.H. Heldin, A. Keller, and C. Betsholtz. (2015).  Functional Characterization of Germline Mutations in PDGFB and PDGFRB in Primary Familial Brain Calcification.  PLoS One 10: e0143407.<BR><HR></TD></TR><TR><TD COLSPAN=5>Vit, O., P. Talacko, Z. Musil, I. Hartmann, K. Pacak, and J. Petrak. (2023).  Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization.  Clin Proteomics 20: 39.<BR><HR></TD></TR><TR><TD COLSPAN=5>Vogel, B.E., J.M. Muriel, C. Dong, and X. Xu. (2006).  Hemicentins: what have we learned from worms?  Cell Res 16: 872-878.<BR><HR></TD></TR><TR><TD COLSPAN=5>Wang, L., M. Astone, S.K. Alam, Z. Zhu, W. Pei, D.A. Frank, S.M. Burgess, and L.H. Hoeppner. (2020).  Suppressing STAT3 activity protects the endothelial barrier from VEGF-mediated vascular permeability.  bioRxiv.<BR><HR></TD></TR><TR><TD COLSPAN=5>Wang, X., J. Zhang, B. Hu, and F. Qian. (2022).  High Expression of CSF-1R Predicts Poor Prognosis and CSF-1R Tumor-Associated Macrophages Inhibit Anti-Tumor Immunity in Colon Adenocarcinoma.  Front Oncol 12: 850767.<BR><HR></TD></TR><TR><TD COLSPAN=5>Wei, R., A. Sugiyama, Y. Sato, M. Nozumi, H. Nishino, M. Takahashi, T. Saito, K. Ando, M. Fukuda, M. Tomomura, M. Igarashi, and S.I. Hisanaga. (2020).  Isoform-dependent subcellular localization of LMTK1A and LMTK1B and their roles in axon outgrowth and spine formation.  J Biochem 168: 23-32.<BR><HR></TD></TR><TR><TD COLSPAN=5>Wei, S., S. Nandi, V. Chitu, Y.G. Yeung, W. Yu, M. Huang, L.T. Williams, H. Lin, and E.R. Stanley. (2010).  Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells.  J Leukoc Biol 88: 495-505.<BR><HR></TD></TR><TR><TD COLSPAN=5>Wilson, M.C., D. Meredith, J.E. Fox, C. Manoharan, A.J. Davies, and A.P. Halestrap.  (2005).  Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). J. Biol. Chem. 280: 27213-27221.  <BR><HR></TD></TR><TR><TD COLSPAN=5>Wong, B.S., E.L. Dunnington, R. Wu, J.I. Kim, K. Hu, T.H. Ro, and D. Fu. (2024).  Facilitated Transport of EGFR Inhibitors Plays an Important Role in Their Cellular Uptake.  Anal Chem 96: 1547-1555.<BR><HR></TD></TR><TR><TD COLSPAN=5>Xie, S., C. Xu, C. Wu, Y. Lou, J. Duan, R. Sang, Z. Lou, J. Hou, W. Ge, Y. Xi, and X. Yang. (2023).  Co-dependent regulation of p-BRAF and potassium channel KCNMA1 levels drives glioma progression.  Cell Mol Life Sci 80: 61.<BR><HR></TD></TR><TR><TD COLSPAN=5>Xu, B., M. Zhang, B. Zhang, W. Chi, X. Ma, W. Zhang, M. Dong, L. Sheng, Y. Zhang, W. Jiao, Y. Shan, W. Chang, P. Wang, S. Wen, D. Pei, L. Chen, X. Zhang, H. Yan, and S. Ye. (2022).  Embigin facilitates monocarboxylate transporter 1 localization to the plasma membrane and transition to a decoupling state.  Cell Rep 40: 111343.<BR><HR></TD></TR><TR><TD COLSPAN=5>Xue, J., V. Rai, D. Singer, S. Chabierski, J. Xie, S. Reverdatto, D.S. Burz, A.M. Schmidt, R. Hoffmann, and A. Shekhtman. (2011).  Advanced glycation end product recognition by the receptor for AGEs.  Structure 19: 722-732.<BR><HR></TD></TR><TR><TD COLSPAN=5>Yeo, G.S., C.C. Connie Hung, J. Rochford, J. Keogh, J. Gray, S. Sivaramakrishnan, S. O'Rahilly, and I.S. Farooqi. (2004).  A de novo mutation affecting human TrkB associated with severe obesity and developmental delay.  Nat Neurosci 7: 1187-1189.<BR><HR></TD></TR><TR><TD COLSPAN=5>You, K., L. Wang, C.H. Chou, K. Liu, T. Nakata, A. Jaiswal, J. Yao, A. Lefkovith, A. Omar, J.G. Perrigoue, J.E. Towne, A. Regev, D.B. Graham, and R.J. Xavier. (2021).  QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasis.  Science 371:.<BR><HR></TD></TR><TR><TD COLSPAN=5>Yu, X., W. Li, H. Liu, X. Wang, C. Coarfa, C. Cheng, X. Yu, Z. Zeng, Y. Cao, K.H. Young, and Y. Li. (2023).  PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination.  J Clin Invest 133:.<BR><HR></TD></TR><TR><TD COLSPAN=5>Yuguchi, T., B.N. Kanoi, H. Nagaoka, T. Miura, D. Ito, H. Takeda, T. Tsuboi, E. Takashima, and H. Otsuki. (2021).  Erythrocyte Binding Like Protein Interacts With Basigin, an Erythrocyte Surface Protein.  Front Cell Infect Microbiol 11: 656620.<BR><HR></TD></TR><TR><TD COLSPAN=5>Zhang, H., X. Tian, X. Lu, D. Xu, Y. Guo, Z. Dong, Y. Li, Y. Ma, C. Chen, Y. Yang, M. Yang, Y. Yang, F. Liu, R. Zhou, M. He, F. Xiao, and X. Wang. (2019).  TMEM25 modulates neuronal excitability and NMDA receptor subunit NR2B degradation.  J Clin Invest 129: 3864-3876.<BR><HR></TD></TR><TR><TD COLSPAN=5>Zhang, L. and L. Xu. (2023).  Fgf2 and Ptpn11 play a role in cerebral injury caused by sevoflurane anesthesia.  Medicine (Baltimore) 102: e36108.<BR><HR></TD></TR><TR><TD COLSPAN=5>Zhen, A., S.R. Krutzik, B.R. Levin, S. Kasparian, J.A. Zack, and S.G. Kitchen. (2014).  CD4 ligation on human blood monocytes triggers macrophage differentiation and enhances HIV infection.  J. Virol. 88: 9934-9946.<BR><HR></TD></TR><TR><TD COLSPAN=5>Zhou, L., L. Zhu, X. Wu, S. Hu, S. Zhang, M. Ning, J. Yu, and M. Chen. (2023).  Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn''s disease.  BMC Med 21: 287.<BR><HR></TD></TR><TR><TD COLSPAN=5><B>Examples:</B><P></TD></TR><TR bgcolor="#99ccff"><TD>TC#</TD><TD>Name</TD><TD>Organismal Type</TD><TD>Example</TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.1"></A><A HREF="tcprotein.php?substrate=8.A.23.1.1&tcname=">8.A.23.1.1</a></TD><TD><b><font color=#3333CC><p>Extracellular chaperone protein precursor, Basigin (BSG; CD147). It interacts with MCT1, 3 and 4 (TC# 2.A.1.13.1, 7 and 9, respectively) (<span id="ref7491.20695846" class="cite">Ovens <em>et al.</em>, 2010</span>; <span id="ref9241.22131303" class="cite">Halestrap 2012</span>).&nbsp; May play a role in cancer progression (<span id="ref34546334.28039486" class="cite">Kendrick <em>et al.</em> 2016</span>). Silencing of CD147 inhibits hepatic stellate cell activation related to suppressing aerobic glycolysis via hedgehog signaling (<span id="ref34553153.33927478" class="cite">Li <em>et al.</em> 2021</span>). CD147 is an integral and potential molecule to abrogate hallmarks of cancer (<span id="ref34557595.38023152" class="cite">Nyalali <em>et al.</em> 2023</span>).</p></TD><TD><b><font color=#3333CC><p>Animals</p></TD><TD><b><font color=#3333CC><p>Basigin precursor of <em>Homo sapiens</em> (P35613)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.10"></A><A HREF="tcprotein.php?substrate=8.A.23.1.10&tcname=">8.A.23.1.10</a></TD><TD><b><font color=#3333CC><p>Activated leukocyte cell adhesion molecule, ALCAM or CD166 antigen, of 583 aas and 2 TMSs, N- and C-terminal.&nbsp; It is expressed on and in the cell membranes of various cells.&nbsp; In the spinal cord dorsal horn (DH), the first gate for the sensory and pain transmission to the brain, ALCAM plays modulatory roles in the excitatory synaptic transmission and plasticity in the (rat) spinal DH (<span id=""ref34548086.28720382"" class=""cite"">Park <em>et al.</em> 2017</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>ALCAM of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.11"></A><A HREF="tcprotein.php?substrate=8.A.23.1.11&tcname=">8.A.23.1.11</a></TD><TD><b><font color=#3333CC><p>Interleukin 1 receptor of 569 aas and 2 TMSs, N-terminal and near the middle of the protein. It is the <span>receptor for IL1A, IL1B and IL1RN. After 
binding to interleukin-1, it associates with the coreceptor IL1RAP to form 
the high affinity interleukin-1 receptor complex which mediates 
interleukin-1-dependent activation of NF-kappa-B, MAPK and other 
pathways. Signaling involves the recruitment of adapter molecules such 
as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of 
the receptor/coreceptor subunits. It binds ligands with comparable affinity,
 and binding of antagonist IL1RN prevents association with IL1RAP to 
form a signaling complex (<span id=""ref34548256.10671496"" class=""cite"">Slack <em>et al.</em> 2000</span>).</span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>IL-1R of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.12"></A><A HREF="tcprotein.php?substrate=8.A.23.1.12&tcname=">8.A.23.1.12</a></TD><TD><b><font color=#3333CC><p>cSrc tyr kinase of 536 aas; regulates the Na<sup>+</sup>,K<sup>+</sup>-ATPase and connexin 43, probably by direct phosphorylation (<span>Giepmans 2006</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>cSrc of<em> Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.13"></A><A HREF="tcprotein.php?substrate=8.A.23.1.13&tcname=">8.A.23.1.13</a></TD><TD><b><font color=#3333CC><p><span class=""recommended-name"">Epidermal growth factor receptor (EGFR) of 1426 aas and 2 or more TMSs.&nbsp; </span><span>Binds to four ligands: Spitz, Gurken, Vein 
and Argos, transducing signals through the 
ras-raf-MAPK pathway. Involved in a myriad of developmental decisions (<span id=""ref34548513.22140578"" class=""cite"">Geiger <em>et al.</em> 2011</span>).</span><span> </span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>EGFR of <em>Drosophila melanogaster </em>(Fruit fly)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.14"></A><A HREF="tcprotein.php?substrate=8.A.23.1.14&tcname=">8.A.23.1.14</a></TD><TD><b><font color=#3333CC><p>Coxsackievirus and adenovirus receptor, CAR, of 365 aas and 2 TMSs near the N- and C-termini. It is a c<span>omponent of the epithelial apical junction 
complex that may function as a homophilic cell adhesion molecule and is 
essential for tight junction integrity. It is also involved in transepithelial
 migration of leukocytes through adhesive interactions with JAML, a 
transmembrane protein of the plasma membrane of leukocytes (<span id="ref34548652.11734628" class="cite">Cohen <em>et al.</em> 2001</span>)</span>. It's subcellular distribution has been studied (<span id="ref34548653.30074059" class="cite">Ifie <em>et al.</em> 2018</span>). The CAR in zebrafish (Q90Y50) has been discussed (<span id="ref34553758.33174233" class="cite">Rathjen 2020</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>CAR of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.15"></A><A HREF="tcprotein.php?substrate=8.A.23.1.15&tcname=">8.A.23.1.15</a></TD><TD><b><font color=#3333CC><p><span class="recommended-name">Ephrin type-B receptor 4</span><span> (EPHB4; <span>EC:<a href="https://enzyme.expasy.org/EC/2.7.10.1">2.7.10.1</a></span>).</span><span class="inner-title" title="A synonym of the recommended name."> Alternative name(s):</span> Hepatoma transmembrane kinase; Tyrosine-protein kinase, TYRO11.&nbsp; It is a <span>receptor tyrosine kinase which binds 
promiscuously transmembrane ephrin-B family ligands residing on adjacent
 cells, leading to contact-dependent bidirectional signaling into 
neighboring cells.&nbsp; It </span><span><span>plays a role in postnatal blood vessel remodeling, morphogenesis and permeability (<span id="ref34548875.16424904" class="cite">Erber <em>et al.</em> 2006</span>; <span id="ref34548876.27400125" class="cite">Martin-Almedina <em>et al.</em> 2016</span>).<br /></span></span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>EPHB4 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.16"></A><A HREF="tcprotein.php?substrate=8.A.23.1.16&tcname=">8.A.23.1.16</a></TD><TD><b><font color=#3333CC><p>Angiopoietin-1 receptor of 1072 aas, Tek, a tyrosyl protein kinase (<span id="ref10998.11969368" class="cite">Ward and Dumont 2002</span>).</p></TD><TD><b><font color=#3333CC><p>Animals</p></TD><TD><b><font color=#3333CC><p>Tek of<em> Mus musculus</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.17"></A><A HREF="tcprotein.php?substrate=8.A.23.1.17&tcname=">8.A.23.1.17</a></TD><TD><b><font color=#3333CC><p>Receptor tyrosyl protein kinase, ErbB4 (ErbB-4).&nbsp; <span>Plays an essential role as cell surface 
receptor for neuregulins and EGF family members and regulates 
development of the heart, the central nervous system and the mammary 
gland, gene transcription, cell proliferation, differentiation, 
migration and apoptosis (<span id="ref34544375.23389757" class="cite">Deng <em>et al.</em> 2013</span>).</span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>ErbB4 of<em> Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.18"></A><A HREF="tcprotein.php?substrate=8.A.23.1.18&tcname=">8.A.23.1.18</a></TD><TD><b><font color=#3333CC><p>Tex14 of 1497 aas and 1 or 2 TMSs.&nbsp; <span>Required both for the formation of 
intercellular bridges during meiosis and for kinetochore-microtubule 
attachment during mitosis. Intercellular bridges, called 'ring canals', probably result from nurse cell fusion with the developing oocyte.&nbsp; They are evolutionarily 
conserved structures that connect differentiating germ cells and are 
required for spermatogenesis, oogenesis and male fertility. They act by promoting the 
conversion of midbodies into intercellular bridges via its interaction 
with CEP55. Interaction with CEP55 inhibits the interaction between 
CEP55 and PDCD6IP/ALIX and TSG101, blocking cell abscission and leading 
to transformation of midbodies into intercellular bridges. In spite of its PK domain, it has no protein kinase activity in vitro (<span id="ref34545219.26917595" class="cite">Lei and Spradling 2016</span>).<br /></span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Tex14 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.19"></A><A HREF="tcprotein.php?substrate=8.A.23.1.19&tcname=">8.A.23.1.19</a></TD><TD><b><font color=#3333CC><p>The Advanced glycosylation end product-specific receptor of 404 aas and 2 TMSs, N- and C-terminal, AGER or RAGE.&nbsp; <span>It is the receptor for amyloid beta peptide, and it contributes to 
the translocation of amyloid-beta peptide (ABPP) across the cell 
membrane from the extracellular to the intracellular space in cortical 
neurons. ABPP-initiated RAGE signaling, especially stimulation of p38 
mitogen-activated protein kinase (MAPK), has the capacity to drive a 
transport system delivering ABPP as a complex with RAGE to the 
intraneuronal space.&nbsp; RAGE also has a number of other functions (<span id="ref34549576.19906677" class="cite">Fang <em>et al.</em> 2010</span>;.<span id="ref34549577.21559403" class="cite">Jin <em>et al.</em> 2011</span></span>). It's structure is known to 1.5 &Aring; resolution (<span id="ref34549578.20943659" class="cite">Park <em>et al.</em> 2010</span>; <span id="ref34549579.21565706" class="cite">Xue <em>et al.</em> 2011</span>).&nbsp; RAGE is a transmembrane receptor of the immunoglobulin family that can bind various endogenous and exogenous ligands, initiating the inflammatory downstream signaling pathways, including inflammaging (<span id="ref34557938.38317623" class="cite">Dascalu <em>et al.</em> 2024</span>).</p>
<p>;</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>RAGE of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.2"></A><A HREF="tcprotein.php?substrate=8.A.23.1.2&tcname=">8.A.23.1.2</a></TD><TD><b><font color=#3333CC><p>Extracellular chaperone protein precursor, Embigin. Interacts with MCT2 (2.A.1.13.5) (<span id="ref7440.20695846" class="cite">Ovens <em>et al.</em>, 2010</span>; <span id="ref9241.22131303" class="cite">Halestrap 2012</span>). Embigin facilitates monocarboxylate transporter 1 localization to the plasma membrane and its transition to a decoupling state (<span id="ref34555436.36103816" class="cite">Xu <em>et al.</em> 2022</span>).</p></TD><TD><b><font color=#3333CC><p>Animals</p></TD><TD><b><font color=#3333CC><p>Embigin of <em>Homo sapiens</em> (Q6PCB8)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.20"></A><A HREF="tcprotein.php?substrate=8.A.23.1.20&tcname=">8.A.23.1.20</a></TD><TD><b><font color=#3333CC><p>Polymeric immunoglobulin receptor-like protein, pIgR, of 562 aas and 2 TMSs, one N-terminal and one near the C-terminus of the protein.&nbsp; It is the receptor for white spot syndrome virus (WSSV)  infection (<span id="ref34549753.30726286" class="cite"><span id="ref34549754.30726286" class="cite">Niu <em>et al.</em> 2019</span></span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>pIgR of <em>Penaeus japonicus </em>(Kuruma prawn)<em><em> </em>(Marsupenaeus japonicus)</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.21"></A><A HREF="tcprotein.php?substrate=8.A.23.1.21&tcname=">8.A.23.1.21</a></TD><TD><b><font color=#3333CC><p>Polymeric Ig-like receptor of 345 aas and 2 TMSs, pIgR, also called Cell adhesion molecule 4 isoform X2.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>pIgR of<em> Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.22"></A><A HREF="tcprotein.php?substrate=8.A.23.1.22&tcname=">8.A.23.1.22</a></TD><TD><b><font color=#3333CC><p>Polymeric Ig-like receptor family protein, pIgR, of 774 aas and 1 TMS, near the C-terminus.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>pIgR of <em>Drosophila melanogaster </em>(Fruit fly)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.23"></A><A HREF="tcprotein.php?substrate=8.A.23.1.23&tcname=">8.A.23.1.23</a></TD><TD><b><font color=#3333CC><p>P<span class="recommended-name">oliovirus receptor-related protein 3-like isoform X, PVRL3, of 366 aas and 1 N-terminal TMS<br /></span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>PVRL3 of <em>Lipotes vexillifer </em>(Yangtze river dolphin)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.24"></A><A HREF="tcprotein.php?substrate=8.A.23.1.24&tcname=">8.A.23.1.24</a></TD><TD><b><font color=#3333CC><p>Uncharacterized protein of 323 aas and 2 TMSs, N- and C-terminal.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>UP of <em><span id="feature_XP_011679692.1_source_0" class="feature">Strongylocentrotus purpuratus</span></em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.25"></A><A HREF="tcprotein.php?substrate=8.A.23.1.25&tcname=">8.A.23.1.25</a></TD><TD><b><font color=#3333CC><p>T-cell surface antigen CD2 of 351 aas. <span>CD2 interacts with lymphocyte function-associated 
antigen CD58 (LFA-3) and CD48/BCM1 to mediate adhesion between T-cells 
and other cell types. CD2 is implicated in the triggering of T-cells,&nbsp; and
the cytoplasmic domain is implicated in the signaling function.</span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>CD2 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.26"></A><A HREF="tcprotein.php?substrate=8.A.23.1.26&tcname=">8.A.23.1.26</a></TD><TD><b><font color=#3333CC><p>Carcinoembryonic antigen-related cell adhesion molecule 1-like protein of 663 aas and 1 TMS.&nbsp; This protein appears to be related to members of family 8.A.128, and these two families may comprise a superfamily.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Adhesin of <em>Xenopus laevis</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.27"></A><A HREF="tcprotein.php?substrate=8.A.23.1.27&tcname=">8.A.23.1.27</a></TD><TD><b><font color=#3333CC><p>TGF-&beta; (Tkv) receptor protein kinase of 575 aas and 1 TMS (<span id="ref34551236.15327786" class="cite">Bartoszewski <em>et al.</em> 2004</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Tkv receptor of<em> </em><em><em>Drosophila melanogaster </em></em>(Fruit fly)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.28"></A><A HREF="tcprotein.php?substrate=8.A.23.1.28&tcname=">8.A.23.1.28</a></TD><TD><b><font color=#3333CC><p>Neural cell adhesion molecule 2-like protein of 567 aas and 2 TMSs, N- and C-terminal.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Adhesion protein of <em>Astatotilapia calliptera</em> (eastern happy)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.29"></A><A HREF="tcprotein.php?substrate=8.A.23.1.29&tcname=">8.A.23.1.29</a></TD><TD><b><font color=#3333CC><p><span>Receptor tyrosine kinase which plays a central 
role in the formation and the maintenance of the neuromuscular junction 
(NMJ), the synapse between the motor neuron and the skeletal muscle 
(<span id="ref34551404.25537362" class="cite">Tan-Sindhunata <em>et al.</em> 2015</span>).
 Recruitment of AGRIN by LRP4 to the MUSK signaling complex induces 
phosphorylation and activation of MUSK, the kinase of the complex (<span id="ref34551398.31411944" class="cite">Koppel <em>et al.</em> 2019</span>).</span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>MUSK of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.3"></A><A HREF="tcprotein.php?substrate=8.A.23.1.3&tcname=">8.A.23.1.3</a></TD><TD><b><font color=#3333CC><p><a></a></p>
<p><!-- test--></p>
<p><a id="8.A.23.1.3"></a></p>
<p>Potassium channel associated protein, contactin 2, CNTN2, of 1040 aas and possibly 2 TMSs, at the N- and C-termini.&nbsp; Mutations are associated with autosomal recessive cortical myoclonic tremors and epilepsy (<a class="reflink" href="result.php?tc=8.A.23#ref9784">Stogmann <em>et al.</em> 2013</a>).</p></TD><TD><b><font color=#3333CC><p>Animals</p></TD><TD><b><font color=#3333CC><p>CNTN2 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.30"></A><A HREF="tcprotein.php?substrate=8.A.23.1.30&tcname=">8.A.23.1.30</a></TD><TD><b><font color=#3333CC><p><span>Insulin receptor-like tyrosine kinase, DAF2, of 1846 aas and 3 putative TMSs, one near the N-terminus, and two in the C-terminal part ofthe protein. It regulates metabolism, controls longevity and prevents developmental 
arrest at the dauer stage (<span id="ref34551485.21334311" class="cite">Fierro-Gonz&aacute;lez <em>et al.</em> 2011</span>; <span id="ref34551486.28853436" class="cite">Tiku <em>et al.</em> 2017</span>; <span id="ref34551487.24332851" class="cite">Chen <em>et al.</em> 2013</span>). </span><span>The nematode insulin receptor (IR), DAF-2B, modulates insulin signaling by sequestration of insulin peptides (<span id="ref34551488.32096469" class="cite">Martinez <em>et al.</em> 2020</span>).</span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>DAF2 of <em>Caenorhabditis elegans</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.31"></A><A HREF="tcprotein.php?substrate=8.A.23.1.31&tcname=">8.A.23.1.31</a></TD><TD><b><font color=#3333CC><p>Hemicentin-1-like protein of 321 aas and 0 - 4 TMSs.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Him1 of <em>Penaeus vannamei</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.32"></A><A HREF="tcprotein.php?substrate=8.A.23.1.32&tcname=">8.A.23.1.32</a></TD><TD><b><font color=#3333CC><p><span>Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family-6, SlamF6, of 351 aas and possibly 3 TMSs, two near the N-terminus, and one near the C-terminus (<span id="ref34551620.15219999" class="cite">Togni <em>et al.</em> 2004</span>). </span><span><span>SLAM receptors, triggered by homo- or heterotypic 
cell-cell interactions, modulate the activation and differentiation
 of a wide variety of immune cells and thus are involved in the 
regulation and interconnection of both innate and adaptive immune 
responses (<span id="ref34551619.18031695" class="cite">Griewank <em>et al.</em> 2007</span>).</span></span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>SlamF6 of <em>Mus musculus </em>(Mouse)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.33"></A><A HREF="tcprotein.php?substrate=8.A.23.1.33&tcname=">8.A.23.1.33</a></TD><TD><b><font color=#3333CC><p>Nephrin, NPHS1 of 1241 aas and two TMSs, one at the N-terminus, and one near the C-terminus of the protein.&nbsp; Nephrin forms a complex with podocin (TC# 3.A.16.1.1), CD2AP (8.A.34.1.5) and TRPC6 (1.A.4.1.5) to form  a macromolecular assembly that constitutes the slit-diaphragm in podocytes, a tight juntion-like complex (<span id="ref34551868.32617419" class="cite">Mulukala <em>et al.</em> 2020</span>).</p>
<p>&nbsp;</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Nephin of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.34"></A><A HREF="tcprotein.php?substrate=8.A.23.1.34&tcname=">8.A.23.1.34</a></TD><TD><b><font color=#3333CC><p>Signal-regulatory protein beta-1, SIRPbeta (SIRP&beta;) of 398 aas and 2 TMSs, N- and C-terminal.&nbsp; <span>It is an immunoglobulin-like cell surface receptor involved
 in the negative regulation of receptor tyrosine kinase-coupled 
signaling processes, and it participates in the recruitment of tyrosine 
kinase SYK. It triggers activation of myeloid cells when associated with 
TYROBP (<span id="ref34550959.10604985" class="cite">Dietrich <em>et al.</em> 2000</span></span>). Positive regulation of phagocytosis by SIRPbeta has been demonstrated as part of&nbsp; its signaling mechanism in macrophages (<span id="ref34551891.15123631" class="cite">Hayashi <em>et al.</em> 2004</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>SIRP&beta; of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.35"></A><A HREF="tcprotein.php?substrate=8.A.23.1.35&tcname=">8.A.23.1.35</a></TD><TD><b><font color=#3333CC><p>Serine/threonine-protein kinase LMTK1 (AATK) of 1374 aas and one N-terminal TMS. It plays a role in axon outgrowth and spine formation (<span id="ref34552389.32044995" class="cite">Wei <em>et al.</em> 2020</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>LMTK1 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.36"></A><A HREF="tcprotein.php?substrate=8.A.23.1.36&tcname=">8.A.23.1.36</a></TD><TD><b><font color=#3333CC><p>CD48 antigen (BCM1; BLAST1; Sgp-60; MEM102; SLAM family member 2, SLAMF2) of 243 aas with 2 TMSs, N- and C-terminal. It is a <span>ligand for CD2, and may facilitate interaction between activated lymphocytes. It is probably involved in regulating T-cell activation (<span id="ref34552939.9927686" class="cite">Gonz&aacute;lez-Cabrero <em>et al.</em> 1999</span>).</span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>BCM1 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.37"></A><A HREF="tcprotein.php?substrate=8.A.23.1.37&tcname=">8.A.23.1.37</a></TD><TD><b><font color=#3333CC><p>Platelet-derived growth factor receptor beta, PDGFRB, a t<span>yrosine-protein kinase that acts as a cell-surface 
receptor for homodimeric PDGFB and PDGFD and for heterodimers formed by 
PDGFA and PDGFB (<span id="ref34553417.1709159" class="cite">Kelly <em>et al.</em> 1991</span>), and plays an essential role in the regulation of 
embryonic development, cell proliferation, survival, Ca<sup>2+</sup> transport, differentiation, 
chemotaxis and migration (<span id="ref34553416.1653029" class="cite">Kazlauskas <em>et al.</em> 1991;</span> <span id="ref34553415.26599395" class="cite">Vanlandewijck <em>et al.</em> 2015</span>). </span>It has been associated with <span style="caret-color: #000000; font-size: 12px; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; -moz-text-size-adjust: auto; -webkit-text-stroke-width: 0px; text-decoration: none; display: inline !important; float: none; font-family: Helvetica; color: #000000;">Primary Familial Brain Calcification (PFBC) (<span id="ref34556532.37240341" class="cite">Monfrini <em>et al.</em> 2023).</span></span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>PDGFRB of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.38"></A><A HREF="tcprotein.php?substrate=8.A.23.1.38&tcname=">8.A.23.1.38</a></TD><TD><b><font color=#3333CC><p>BDNF/NT-3 growth factors receptor, ofNKRK2 or TrkB, of 822 aas and 1 N-terminal TMS. It is a <span>receptor
 tyrosine kinase involved in the development and the maturation of the 
central and the peripheral nervous systems through regulation of neuron 
survival, proliferation, migration, differentiation, and synapse 
formation and plasticity. It is a </span><span>receptor for BDNF/brain-derived neurotrophic factor and 
NTF4/neurotrophin-4. Alternatively, it can bind NTF3/neurotrophin-3 
which is less efficient in activating the receptor but regulates neuron 
survival through NTRK2 (<span id="ref34553536.7574684" class="cite">Haniu <em>et al.</em> 1995</span>, <span id="ref34553537.15494731" class="cite">Yeo <em>et al.</em> 2004</span>). </span>Upon ligand-binding, it undergoes homodimerization, autophosphorylation and activation (<span id="ref34553537.15494731" class="cite">Yeo <em>et al.</em> 2004</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>TrkB of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.39"></A><A HREF="tcprotein.php?substrate=8.A.23.1.39&tcname=">8.A.23.1.39</a></TD><TD><b><font color=#3333CC><p><span style="font-weight: normal;">Receptor tyrosine-protein kinase ErbB-2/ErbB-3. ErbB-2 is also called </span><span class="shortName">ERBB2, HER2, MLN19, NEU and NGL. It is of 1255 aas and possibly 2 TMSs, one at the N-terminus, and one large hydrophobic peak in the C-terminal half of the protein. ErbB-3 is also called HER3 and is of 1342 aas with at least one TMS near residue 650, but maybe also an N-terminal TMS. These two proteins form a complex with&nbsp; SorLA (TC# 9.B.87.1.17) (<span id="ref34553802.33420373" class="cite">Al-Akhrass <em>et al.</em> 2021</span>). They are </span><span class="shortName"><span>parts of several cell surface receptor 
complexes that apparently need a coreceptor for ligand binding. They are essential components of a neuregulin-receptor complex (<span id="ref34553803.20682778" class="cite">Ieguchi <em>et al.</em> 2010</span>).<br /></span></span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>HER2/HER3 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.4"></A><A HREF="tcprotein.php?substrate=8.A.23.1.4&tcname=">8.A.23.1.4</a></TD><TD><b><font color=#3333CC>Canalicular bile acid transporter (C-BAT) ecto-ATPase (GP110) </TD><TD><b><font color=#3333CC>Mammalian liver </TD><TD><b><font color=#3333CC>C-BAT (GP110) of <I>Rattus norvegicus </I></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.40"></A><A HREF="tcprotein.php?substrate=8.A.23.1.40&tcname=">8.A.23.1.40</a></TD><TD><b><font color=#3333CC><p>Bone morphogenetic protein receptor type-1B, BMPR-1B or FecB, of 502 aas and one large peak of hydrophobicity at ~residue 140, as well as four smaller peaks of hydrophobicity nearer the C-terminus of the protein that could be TMSs (<span id="ref34554433.34838638" class="cite">Lv <em>et al.</em> 2022</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>fecB of <em>Ovis aries</em> (sheep)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.41"></A><A HREF="tcprotein.php?substrate=8.A.23.1.41&tcname=">8.A.23.1.41</a></TD><TD><b><font color=#3333CC><p>Macrophage colony-stimulating factor 1 receptor, CSF1R or FMS of 972 aas and 2 or 3 TMSs, one at the N-terminus, one large peak of hydrophobicity at ~ residue 520, and a much smaller peak at residue 650. It is a <span>tyrosine-protein kinase that acts as a cell-surface 
receptor for CSF1 and IL34 and plays an essential role in the regulation
 of survival, proliferation and differentiation of hematopoietic 
precursor cells, especially mononuclear phagocytes, such as macrophages 
and monocytes. It promotes the release of proinflammatory chemokines in 
response to IL34 and CSF1, and thereby plays an important role in innate
 immunity and in inflammatory processes. </span><span>It regulates bone resorption and is required for normal bone 
and tooth development. It is also required for normal male and female fertility, 
and for normal development of milk ducts. It </span><span>promotes cancer cell invasion and activates several 
signaling pathways in response to ligand binding, including the ERK1/2 
and the JNK pathways (<span id="ref34554638.20504948" class="cite">Wei <em>et al.</em> 2010</span>, <span id="ref34554639.30982609" class="cite">Guo <em>et al.</em> 2019</span>). </span>High expression of CSF-1R predicts poor prognosis in colon adenocarcinoma (<span id="ref34554640.35444953" class="cite">Wang <em>et al.</em> 2022</span>).</p>
<p>&nbsp;</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>CSF1R of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.42"></A><A HREF="tcprotein.php?substrate=8.A.23.1.42&tcname=">8.A.23.1.42</a></TD><TD><b><font color=#3333CC><p>Dual leucine zipper kinase, Dlk, or mitogen-activated protein kinase kinase kinase 12, MAP3K12, of 859 aas and possibly two adjacent TMSs.&nbsp; It is <span>part of a non-canonical MAPK signaling pathway (<span id="ref34554756.28111074" class="cite">Huang <em>et al.</em> 2017</span>).</span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>DLK of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.43"></A><A HREF="tcprotein.php?substrate=8.A.23.1.43&tcname=">8.A.23.1.43</a></TD><TD><b><font color=#3333CC><p>Vascular endothelial growth factor receptor 3,VGFR3, of 1363 aas and 2 TMSs, N-terminal and at residue 780.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>VGFR3 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.44"></A><A HREF="tcprotein.php?substrate=8.A.23.1.44&tcname=">8.A.23.1.44</a></TD><TD><b><font color=#3333CC><p>Proto-oncogene tyrosine-protein kinase receptor, Ret, of 1114 aas and 2 TMSs. N-terminal and at residue 645. The cryoEM structure is available (<span id="ref34554884.35715229" class="cite">Cai <em>et al.</em> 2022</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>RET of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.45"></A><A HREF="tcprotein.php?substrate=8.A.23.1.45&tcname=">8.A.23.1.45</a></TD><TD><b><font color=#3333CC><p>Hepatocyte growth factor receptor, Met, of 1390 aas and 2 TMSs, one N-terminal and one at residue 945. A cryoEM strucure is available (<span id="ref34554884.35715229" class="cite">Cai <em>et al.</em> 2022</span>).</p>
<p>&nbsp;</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>MET of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.46"></A><A HREF="tcprotein.php?substrate=8.A.23.1.46&tcname=">8.A.23.1.46</a></TD><TD><b><font color=#3333CC><p>Epidermal growth factor receptor, EGFR, of 1210 aas and two TMSs, one N-terminal and one at residue 655. The CryoEM 3-d structure is available (<span id="ref34554884.35715229" class="cite">Cai <em>et al.</em> 2022</span>).&nbsp; Receptor tyrosine kinase binding ligands of the EGF family activate several signaling cascades to convert extracellular cues into
 appropriate cellular responses (<span id="ref34549106.27153536" class="cite">Runkle <em>et al.</em> 2016</span>). Two FDA-approved EGFR inhibitor drugs 
(lapatinib and afatinib) inside living cells and the changes in their 
cellular uptake upon the addition of organic cation transporter 
inhibitors have been reported (<span id="ref34557684.38214696" class="cite">Wong <em>et al.</em> 2024</span>).&nbsp; EGFR, a transmembrane protein commonly targeted by tyrosine kinase inhibitors (TKIs) as a front-line therapy for patients with many cancers including nonsmall cell lung cancer (NSCLC). Effective treatment requires efficient intracellular drug uptake and target binding, but despite the recent success in the development of new TKI drugs,&nbsp; TKI drugs are sequestered in lysosomes.&nbsp; Two Food and Drug Administration-approved EGFR inhibitory drugs (lapatinib and afatinib) inside living cells and the changes in their cellular uptake by facilitated diffusion upon the addition of organic cation transporter inhibitors has been recorded (<span id="ref34557684.38214696" class="cite">Wong <em>et al.</em> 2024</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>EGFR of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.47"></A><A HREF="tcprotein.php?substrate=8.A.23.1.47&tcname=">8.A.23.1.47</a></TD><TD><b><font color=#3333CC><p>Receptor tyrosine-protein kinase ErbB-2 or HERS of 1255 aas and one TMS at residue 350.&nbsp; A 3-d cryoEM structure is available (<span id="ref34554884.35715229" class="cite">Cai <em>et al.</em> 2022</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>EbrB-2 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.48"></A><A HREF="tcprotein.php?substrate=8.A.23.1.48&tcname=">8.A.23.1.48</a></TD><TD><b><font color=#3333CC><p>Serine, threonine protein kinase B, BraF, of 766 aas and probably 0 TMSs. In thyroid cancer, BRAF V600E regulates the mitochondrial permeability transition through the pERK-pGSK-CypD pathway to resist death, providing intervention targets for BRAF V600E mutant tumours (<span id="ref34555122.35748101" class="cite">Gao <em>et al.</em> 2022</span>). Co-dependent regulation of p-BRAF and potassium channel KCNMA1 (TC# 1.A.1.3.10) levels drives glioma progression (<span id="ref34555935.36763212" class="cite">Xie <em>et al.</em> 2023</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>BraF of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.49"></A><A HREF="tcprotein.php?substrate=8.A.23.1.49&tcname=">8.A.23.1.49</a></TD><TD><b><font color=#3333CC><p>Neural cell adhesion molecule, NCAM, of 858 aas. This glycoprotein interacts with TrpC1, C4 and C5 to enhance their Ca<sup>2+</sup> transport activities (<span id="ref34555445.36077460" class="cite">Amores-Bonet <em>et al.</em> 2022</span>)</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>NCAM proteins of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.5"></A><A HREF="tcprotein.php?substrate=8.A.23.1.5&tcname=">8.A.23.1.5</a></TD><TD><b><font color=#3333CC><p>Hepatocyte cell adhesion molecule (CAM) precursor of 416 aas.&nbsp; Important for interactions, trafficking and function of&nbsp; ClC2 (CLC-2) in several tissues including the nervious system where it influences human leukodystrophies (<span id="ref34544137.26033718" class="cite">Capdevila-Nortes <em>et al.</em> 2015</span>).</p></TD><TD><b><font color=#3333CC><p>Animals</p></TD><TD><b><font color=#3333CC><p>CAM of<em> Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.50"></A><A HREF="tcprotein.php?substrate=8.A.23.1.50&tcname=">8.A.23.1.50</a></TD><TD><b><font color=#3333CC><p>Ser/Thr protein kinase, WNK4, of 1243 aas and possibly 2 TMSs. Plays a role in the regulation of electrolyte homeostasis, cell signaling, survival and 
proliferation. It acts as an activator and inhibitor of sodium-coupled 
chloride cotransporters and potassium-coupled chloride cotransporters, respectively (<span id="ref34555498.36272750" class="cite">Hoorn and de Baaij 2022</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>WNK4 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.51"></A><A HREF="tcprotein.php?substrate=8.A.23.1.51&tcname=">8.A.23.1.51</a></TD><TD><b><font color=#3333CC><p><span class="highlight">General</span> <span class="highlight">control</span> <span class="highlight">nonderepressible</span> kinase 2 of 1699 aas and 0-2 TMSs. Also called eukaryotic translation initiation factor 2-alpha kinase, Gcn-2. Serine/threonine-protein kinase which phosphorylates the alpha subunit 
of eukaryotic translation-initiation factor 2 (eIF2alpha), leading to 
its inactivation and thus to a rapid reduction of translational 
initiation and repression of global protein synthesis.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Gcn-2 of <em>Caenorhabditis elegans</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.52"></A><A HREF="tcprotein.php?substrate=8.A.23.1.52&tcname=">8.A.23.1.52</a></TD><TD><b><font color=#3333CC><p>Receptor-interacting serine/threonine-protein kinase 3, RIPK3 of 518 aas and probably 0 TMSs. It modulates sarcoma through immune checkpoint HAVCR2 and regulates the TMC8 channel (TC# 1.A.17.4.11).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>RIPK3 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.53"></A><A HREF="tcprotein.php?substrate=8.A.23.1.53&tcname=">8.A.23.1.53</a></TD><TD><b><font color=#3333CC><p>Insulin-like growth factor 1 receptor (chain F) (IGF1R) of 952 aas, possibly with 4 N-terminal TMSs. It is antagonized by viral insulin/IGF-1-like peptides (e.g., VILP of 72 aas and no TMSs (<span id="ref34555664.36335114" class="cite">Moreau <em>et al.</em> 2022</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>IGF-1 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.54"></A><A HREF="tcprotein.php?substrate=8.A.23.1.54&tcname=">8.A.23.1.54</a></TD><TD><b><font color=#3333CC><p>Leucine-rich repeat serine/threonine-protein kinase 2, LRRK2 or PARK8, of 2527 aas. Plays an important role in recruiting SEC16A to endoplasmic reticulum 
exit sites (ERES) and in regulating ER to Golgi vesicle-mediated 
transport and ERES organization (<span id="ref34555735.25201882" class="cite">Cho <em>et al.</em> 2014</span>). It positively regulates autophagy through calcium-dependent activation of the CaMKK/AMPK signaling pathway (<span id="ref34555736.22012985" class="cite">G&oacute;mez-Suaga <em>et al.</em> 2012</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>LRRK2 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.55"></A><A HREF="tcprotein.php?substrate=8.A.23.1.55&tcname=">8.A.23.1.55</a></TD><TD><b><font color=#3333CC><p>Platelet-derived growth factor receptor-like protein, DPGFRL, of 375 aas. It is a biomarker for endometriosis (EM), a common gynecological disorder that often leads to irregular menstruation and infertility (<span id="ref34555776.36524127" class="cite">Jiang <em>et al.</em> 2022</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>DPGFRL of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.56"></A><A HREF="tcprotein.php?substrate=8.A.23.1.56&tcname=">8.A.23.1.56</a></TD><TD><b><font color=#3333CC><p>V-set and transmembrane domain-containing protein 2-like (VSTM2L) of 204 aas and 2 TMSs, N- and C-terminal. It is a crucial gene closely associated with ovarian cancer metastasis, progression, and prognosis (<span id="ref34556428.37030064" class="cite">Li <em>et al.</em> 2023</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>VSTM2L of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.57"></A><A HREF="tcprotein.php?substrate=8.A.23.1.57&tcname=">8.A.23.1.57</a></TD><TD><b><font color=#3333CC><p>Translation initiation factor 2-alpha kinase 3, PERK, of 1116 aas and at least 2 TMSs, one at the N-terminus and one at about residue 530.&nbsp; There are also three smaller peaks of hydrophobicity near the C-terminus of the protein that could be TMSs.&nbsp; It is a metabolic-stress sensing protein kinase that phosphorylates the alpha 
subunit of eukaryotic translation initiation factor 2 
(EIF2S1/eIF-2-alpha) in response to various stress conditions. It is a key 
activator of the integrated stress response (ISR) required for 
adaptation to various stresses, such as the unfolded protein response (UPR) 
and low amino acid availability. EIF2S1/eIF-2-alpha 
phosphorylation in response to stress converts EIF2S1/eIF-2-alpha in a 
global protein synthesis inhibitor, leading to a global attenuation of 
cap-dependent translation, while concomitantly initiating the 
preferential translation of ISR-specific mRNAs, such as the 
transcriptional activators ATF4 and QRICH1, and hence allowing ATF4- and
 QRICH1-mediated reprogramming (<span id="ref34556657.33384352" class="cite">You <em>et al.</em> 2021</span>). PERK/ATF3-reduced ER stress in a high potassium environment suppresses&nbsp; tumor ferroptosis (<span id="ref34556658.37283787" class="cite">Pu <em>et al.</em> 2023</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>PERK of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.58"></A><A HREF="tcprotein.php?substrate=8.A.23.1.58&tcname=">8.A.23.1.58</a></TD><TD><b><font color=#3333CC><p>Transmembrane and immunoglobulin domain-containing protein 1, TMIGD(1), isoform 2 precursor of 218 aas with 1 N-terminal TMS plus one possible TMS at about residue 120. The functions of TMIGD1 have been reviewed and include those of a tumor supressor and an adhesion receptor (<span id="ref34556718.37087524" class="cite">Th&uuml;ring <em>et al.</em> 2023</span>; <span id="ref34556719.35481970" class="cite">Mu <em>et al.</em> 2022</span>). Macrophage-derived exosomes promote intestinal mucosal barrier dysfunction in inflammatory bowel disease by regulating TMIGD1 via mircroRNA-223 (<span id="ref34556720.37301121" class="cite">Chang <em>et al.</em> 2023</span>).&nbsp; Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-kappaB pathway in Crohn's disease (<span id="ref34557069.37542259" class="cite">Zhou <em>et al.</em> 2023</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>TMIGD1 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.59"></A><A HREF="tcprotein.php?substrate=8.A.23.1.59&tcname=">8.A.23.1.59</a></TD><TD><b><font color=#3333CC><p>Roundabout homolog 2-like protein of 1319 aas and two TMSs, one at the N-terminus and one at about residues 880.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Roundabout2 of <em>Anopheles merus</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.6"></A><A HREF="tcprotein.php?substrate=8.A.23.1.6&tcname=">8.A.23.1.6</a></TD><TD><b><font color=#3333CC><p>Fibroblast growth factor receptor-like protein, FGFRL1, of 504 aas and 2 TMSs, one N-terminal and one C-terminal. It is capable of inducing syncytium formation  (<span id="ref34546520.20851884" class="cite">Steinberg <em>et al.</em> 2010</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>FGFRL-1 of<em> Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.60"></A><A HREF="tcprotein.php?substrate=8.A.23.1.60&tcname=">8.A.23.1.60</a></TD><TD><b><font color=#3333CC><p>Tyrosine-protein kinase transmembrane receptor, ROR1, of 937 aas and two TMSs, one at the N-terminus and one large hydrophobic peak at about residue 420.&nbsp; Extracellular vesicle-associated tyrosine kinase-like orphan receptors, ROR1 and ROR2, promote breast cancer progression (<span id="ref34556894.37430307" class="cite">Irmer <em>et al.</em> 2023</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>ROR1 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.61"></A><A HREF="tcprotein.php?substrate=8.A.23.1.61&tcname=">8.A.23.1.61</a></TD><TD><b><font color=#3333CC><p>Uncharacterized protein of 412 aas and 2 TMSs, one N-terminal and one near the C-terminus. NOTE: This family may be homologous to families 8.A.128 and 9.B.454, do these three families may conprise a Superfamily.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>UP of <em>Dreissena polymorpha</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.62"></A><A HREF="tcprotein.php?substrate=8.A.23.1.62&tcname=">8.A.23.1.62</a></TD><TD><b><font color=#3333CC><p>Neural cell adhesion molecule L1, LICAM or CD171, of 1257 aas and 2 TMSs, N- and C-terminal. It is involved in the dynamics of cell adhesion and in the generation of transmembrane signals via tyrosine kinase receptors. During brain development, it is critical in multiple processes, including neuronal migration, axonal growth, fasciculation, and synaptogenesis. In the mature brain, it plays a role in the dynamics of neuronal structure and function, including synaptic plasticity (<span id="ref34557117.20621658" class="cite">Sch&auml;fer <em>et al.</em> 2010</span>).&nbsp; <span style="text-decoration: underline;">Interaction of L1CAM with LC3 is required for L1-dependent neurite outgrowth and neuronal survival (<span id="ref34557118.37569906" class="cite">Loers <em>et al.</em> 2023</span>).</span></p>
<p>&nbsp;</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>LICAM of<em> Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.63"></A><A HREF="tcprotein.php?substrate=8.A.23.1.63&tcname=">8.A.23.1.63</a></TD><TD><b><font color=#3333CC><p>Carcinoembryonic antigen-related cell adhesion molecule 6 preproprotein (CEACAM6) is of 344 aas and 1 C-terminal TMS.&nbsp; Non-coding microRNAs (miRNAs) play critical roles in tumor progression and hold promise as therapeutic agents for multiple cancers. MicroRNA 29a (miR-29a) is a tumor suppressor miRNA that inhibits cancer cell growth and tumor progression in non-small cell lung cancer. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6), which plays an important role in lung cancer progression, has been identified as a target of miR-29a. Delivery of miR-29a to lung adenocarcinoma cells has therapeutic potential as a unique cancer treatment approach (<span id="ref34557265.37684602" class="cite">Son <em>et al.</em> 2023</span>).</p>
<p>&nbsp;</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.64"></A><A HREF="tcprotein.php?substrate=8.A.23.1.64&tcname=">8.A.23.1.64</a></TD><TD><b><font color=#3333CC><p>CD146, MCAM or MUC18 of 646 aas with 2 TMSs, N- and C-terminal.&nbsp; It plays a role in cell adhesion, and in cohesion of the endothelial 
monolayer at intercellular junctions in vascular tissues (<span id="ref34557313.11036077" class="cite">Anfosso <em>et al.</em> 2001</span>). Its expression 
may allow melanoma cells to interact with cellular elements of the 
vascular system, thereby enhancing hematogeneous tumor spread. It could be 
an adhesion molecule active in neural crest cells during embryonic 
development. It acts as a surface receptor that triggers tyrosine 
phosphorylation of FYN and PTK2/FAK1, and a transient increase in the 
intracellular calcium concentration (<span id="ref34557312.8292890" class="cite">Johnson <em>et al.</em> 1993</span>). It is a possible drug target for pheochromocytomas and paragangliomas (PPGLs), rare neuroendocrine tumors (<span id="ref34557314.37749499" class="cite">Vit <em>et al.</em> 2023</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>CD146 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.65"></A><A HREF="tcprotein.php?substrate=8.A.23.1.65&tcname=">8.A.23.1.65</a></TD><TD><b><font color=#3333CC><p>eIF-2-alpha kinase, GCN2, of 1648 aas and an undetermined number of putative TMSs, possibly none.&nbsp; It is a metabolic-stress-sensing protein kinase that phosphorylates the alpha 
subunit of eukaryotic translation initiation factor 2 
(EIF2S1/eIF-2-alpha) in response to low amino acid availability (<span id="ref34557486.26102367" class="cite">Lehman <em>et al.</em> 2015</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>GCN2 of <em>Mus musculus</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.66"></A><A HREF="tcprotein.php?substrate=8.A.23.1.66&tcname=">8.A.23.1.66</a></TD><TD><b><font color=#3333CC><p>Platelet-derived growth factor receptor alpha, Pdgfra, of 1089 aas and 2 TMSs, one N-terminal and one at ~ residue 530.&nbsp; It is a tyrosine-protein kinase that acts as a cell-surface receptor for PDGFA, 
PDGFB and PDGFC and plays an essential role in the regulation of 
embryonic development, cell proliferation, survival and chemotaxis. 
Depending on the context, promotes or inhibits cell proliferation and 
cell migration. Plays an important role in the differentiation of bone 
marrow-derived mesenchymal stem cells. Required for normal skeleton 
development and cephalic closure during embryonic development (<span id="ref34557569.12808148" class="cite">Griffin <em>et al.</em> 2003</span>). See also TC# 2.A.1.1.28 (<span id="ref34557568.37960778" class="cite">Zhang and Xu 2023</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Pdgfra of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.7"></A><A HREF="tcprotein.php?substrate=8.A.23.1.7&tcname=">8.A.23.1.7</a></TD><TD><b><font color=#3333CC><p>Fibroblast growth factor receptor 1, FGFR1, of822 aas and 2 TMSs, one N-terminal and one central.&nbsp; <span>FGFR1 is a tyrosine-protein kinase that acts as 
cell-surface receptor for fibroblast growth factors and plays an 
essential role in the regulation of embryonic development, cell 
proliferation, differentiation and migration. Required for normal 
mesoderm patterning and correct axial organization during embryonic 
development, normal skeletogenesis and normal development of the 
gonadotropin-releasing hormone (GnRH) neuronal system (<span id="ref34546948.28197342" class="cite">Haenzi and Moon 2017</span>).</span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>FGFR1 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.8"></A><A HREF="tcprotein.php?substrate=8.A.23.1.8&tcname=">8.A.23.1.8</a></TD><TD><b><font color=#3333CC><p>Neuroplastin NptN of 398 aas (<span>Beesley <em>et al.</em> 2014</span>).&nbsp; Important for targetting of certain transporters such as Xkr8 to the plasma membrane with which it, with basigin, forms a physical complex (<span>Suzuki <em>et al.</em> 2016</span>). Neuroplastin expression is essential for hearing and hair cell PMCA (TC# 3.A.3.2.40) expression (<span id="ref34554218.33844052" class="cite">Lin <em>et al.</em> 2021</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>NptN of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.1.9"></A><A HREF="tcprotein.php?substrate=8.A.23.1.9&tcname=">8.A.23.1.9</a></TD><TD><b><font color=#3333CC><p>Fibroblast growth factor receptor 4, FGFR4, of 802 aas and 2 - 4 TMSs.&nbsp; Serves as the receptor for FGF23 for the activation of TRP6 (TC# 1.A.4.1.5). Binding activates the TRP6 channel for inorganic cation (including Ca<sup>2+</sup>) transport (<span id="ref34547513.28919046" class="cite">Smith <em>et al.</em> 2017</span>). It also regulates Na+:phosphate co-transport together with &alpha;-Klotho (see paragraph 2 in the family description of TC# 1.A.108; <span id="ref34549093.30506274" class="cite">Hu <em>et al.</em> 2018</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>FGFR4 of<em> Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR><TD COLSPAN=5><B>Examples:</B><P></TD></TR><TR bgcolor="#99ccff"><TD>TC#</TD><TD>Name</TD><TD>Organismal Type</TD><TD>Example</TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.2.1"></A><A HREF="tcprotein.php?substrate=8.A.23.2.1&tcname=">8.A.23.2.1</a></TD><TD><b><font color=#3333CC><p>T-cell surface glycoprotein, CD4, of 458 aas and 2 TMSs, N- and C-terminal.&nbsp; It is the receptor for HIV and other viruses (see family description) (<span id="ref34551257.32106536" class="cite">Raphael <em>et al.</em> 2020</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>CD4 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.2.2"></A><A HREF="tcprotein.php?substrate=8.A.23.2.2&tcname=">8.A.23.2.2</a></TD><TD><b><font color=#3333CC><p>CD4-like protein 2 of 429 aas and 2 TMSs, N- and C-terminal.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>CD4 of <em>Ctenopharyngodon idella</em> (grass carp)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.2.3"></A><A HREF="tcprotein.php?substrate=8.A.23.2.3&tcname=">8.A.23.2.3</a></TD><TD><b><font color=#3333CC><p>Lymphocyte activation gene 3 protein of 487 aas and 2 TMSs, one N-terminal and one C-terminal.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Lymphocyte activation protein of<em> Thamnophis elegans</em> (Western garter snake)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.2.4"></A><A HREF="tcprotein.php?substrate=8.A.23.2.4&tcname=">8.A.23.2.4</a></TD><TD><b><font color=#3333CC><p>Neural cell adhesion molecule 2-like protein of 496 aas and 2 TMSs, N- and C-terminal.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Cell adhestion protein of <em>Tachysurus fulvidraco</em> (yellow cat fish)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.2.5"></A><A HREF="tcprotein.php?substrate=8.A.23.2.5&tcname=">8.A.23.2.5</a></TD><TD><b><font color=#3333CC><p>Uncharacterized protein of 414 aas and 2 TMSs, N- and C-terminal.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>UP of <em>Colinus virginianus</em> (northern bobwhite)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.2.6"></A><A HREF="tcprotein.php?substrate=8.A.23.2.6&tcname=">8.A.23.2.6</a></TD><TD><b><font color=#3333CC><p>CD16A (Fc&gamma;RIIIA, FCGR3A, FCG3, FCGR3, IGFR3) antiinflamatory protein of 254 aas and 2 TMSs, N- and C-terminal (<span id="ref34553309.24728843" class="cite">Ben Mkaddem <em>et al.</em> 2014</span>). It is a <span>receptor for the Fc region of IgG. It binds complexed
 or aggregated IgG and also monomeric IgG and mediates antibody-dependent 
cellular cytotoxicity (ADCC) and other antibody-dependent responses, 
such as phagocytosis (<span id="ref34553307.21768335" class="cite">Ferrara <em>et al.</em> 2011</span>, <span id="ref34553308.22023369" class="cite">Mizushima <em>et al.</em> 2011</span>).<br /></span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>CD16A of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.2.7"></A><A HREF="tcprotein.php?substrate=8.A.23.2.7&tcname=">8.A.23.2.7</a></TD><TD><b><font color=#3333CC><p>CD16B of 233 aas and 2 TMSs, N- and C-terminal. It m<span>ay serve as a trap for immune complexes in the peripheral circulation which does not activate neutrophils. </span><span>Microinflammation status, involving CD16, observed in chronic kidney disease patients is associated with endothelial damage (<span id="ref34553310.17684360" class="cite">Ramirez <em>et al.</em> 2007</span>). A 3-d cryoEM strcuture is available (<span id="ref34554884.35715229" class="cite">Cai <em>et al.</em> 2022</span>).<br /></span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>CD16B of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR><TD COLSPAN=5><B>Examples:</B><P></TD></TR><TR bgcolor="#99ccff"><TD>TC#</TD><TD>Name</TD><TD>Organismal Type</TD><TD>Example</TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.3.1"></A><A HREF="tcprotein.php?substrate=8.A.23.3.1&tcname=">8.A.23.3.1</a></TD><TD><b><font color=#3333CC><p>TMEM25 of 366 aas and up to 4 TMSs, scattered throughout the protein (N-terminal, C-terminal and at residues ~150 and 250. The expression of&nbsp; Tmem25 is strongly influenced by glutamate ionotropic receptor kainate type subunit 4, and it is primarily localized to late endosomes in neurons (<span id="ref34551517.31424425" class="cite">Zhang <em>et al.</em> 2019</span>). The effects of TMEM25 on neuronal excitability are likely mediated by N-methyl-D-aspartate receptors. TMEM25 affects the expression of the NR2B subunit and interacts with NR2B; both colocalize to late endosome compartments. TMEM25 induces acidification changes in lysosome compartments and accelerates the degradation of NR2B, and TMEM25 expression is decreased in brain tissues from patients with epilepsy and epileptic mice. TMEM25 overexpression attenuated the behavioral phenotypes of epileptic seizures, whereas TMEM25 downregulation exerted the opposite effect (<span id="ref34551517.31424425" class="cite">Zhang <em>et al.</em> 2019</span>). TMEM25 inhibits monomeric epidermal growth factor receptor (EGFR)-mediated STAT3 activation in the basal state to suppress triple-negative breast cancer progression (<span id="ref34556473.37095176" class="cite">Bi <em>et al.</em> 2023</span>).&nbsp; In neurons, TMEM25 modulates the degradation of the NMDA receptor GRIN2B subunit. Thus, TMEM25 regulates neuronal excitability (<span id="ref34557506.37846797" class="cite">An <em>et al.</em> 2023</span>).&nbsp; TMEM25 is a Par3-binding protein that attenuates claudin assembly during tight junction development (<span id="ref34557736.38177906" class="cite">Kamakura <em>et al.</em> 2024</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>TMEM25 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.3.2"></A><A HREF="tcprotein.php?substrate=8.A.23.3.2&tcname=">8.A.23.3.2</a></TD><TD><b><font color=#3333CC><p>TMEM25-like protein,  isoform X3 of 169 aas and 1 TMS.</p>
<p></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>TMEM25 of <em>Pteropus alecto</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.3.3"></A><A HREF="tcprotein.php?substrate=8.A.23.3.3&tcname=">8.A.23.3.3</a></TD><TD><b><font color=#3333CC><p>TMEM25 protein of 279 aas and 1 TMS. It may be an incomplete sequence.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>TMEM25 of<em> Neopelma chrysocephalum</em> (saffron-crested tyrant-manakin)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR><TD COLSPAN=5><B>Examples:</B><P></TD></TR><TR bgcolor="#99ccff"><TD>TC#</TD><TD>Name</TD><TD>Organismal Type</TD><TD>Example</TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.4.1"></A><A HREF="tcprotein.php?substrate=8.A.23.4.1&tcname=">8.A.23.4.1</a></TD><TD><b><font color=#3333CC><p>Intercellular adhesion molecule 1, ICAM-1 or ICAM1, of 532 aas and 2 TMSs, N- and C-terminal. <span>During leukocyte trans-endothelial migration, ICAM1 engagement promotes the assembly of endothelial apical cups (<span id="ref34552150.11173916" class="cite">Hayashi <em>et al.</em> 2001</span>; <span id="ref34552151.17875742" class="cite">van Buul <em>et al.</em> 2007</span>). </span>STAT3-dependent transcriptional regulation of ICAM-1, an endothelial transmembrane protein, regulates vascular permeability in endothelial cells (<span id="ref34552152.33140053" class="cite">Wang <em>et al.</em> 2020</span>). <span id="ref34557124.37619906" class="cite">Martin <em>et al.</em> 2023 </span>reviewed the role of ICAM-1 during both autoimmunity and islet graft rejection to understand the mechanism(s) leading to islet beta-cell death and dysfunction that results from insufficient circulating quantities of insulin to control glucose homeostasis.</p>
<p>&nbsp;</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>ICAM1 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.4.2"></A><A HREF="tcprotein.php?substrate=8.A.23.4.2&tcname=">8.A.23.4.2</a></TD><TD><b><font color=#3333CC><p>Vascular cell adhesion protein 1-like protein of 677 aas and probably two TMSs, N- and C-terminal.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Vascular cell adhesion protein 1 of <em>Bufo bufo</em> (common toad)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.4.3"></A><A HREF="tcprotein.php?substrate=8.A.23.4.3&tcname=">8.A.23.4.3</a></TD><TD><b><font color=#3333CC><p>Hemicentin-1 of 590 aas and possibly two TMSs, one N-terminal and one near the C-terminus of the protein. <span>Hemicentins are conserved extracellular matrix proteins 
discovered in <em>Caenorhabditis elegans</em>, with orthologs in all vertebrate 
species including humans </span> (<span id="ref34553681.17031392" class="cite">Vogel <em>et al.</em> 2006</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Hemicentin 1 of <em>Sander lucioperca</em> (pikeperch)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR><TD COLSPAN=5><B>Examples:</B><P></TD></TR><TR bgcolor="#99ccff"><TD>TC#</TD><TD>Name</TD><TD>Organismal Type</TD><TD>Example</TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.5.1"></A><A HREF="tcprotein.php?substrate=8.A.23.5.1&tcname=">8.A.23.5.1</a></TD><TD><b><font color=#3333CC><p>Programmed cell death 1 ligand 1, PDL1, CD274, B7H1, PDCD1L1, or PDCD1LG1, of 290 aas and 2 TMSs, one N-terminal and one C-terminal. It plays a role in induction of immune tolerance to self. It plays a critical role in induction and maintenance of immune tolerance to self (<span id="ref34553677.11015443" class="cite">Freeman <em>et al.</em> 2000</span>, <span id="ref34553678.28813417" class="cite">Burr <em>et al.</em> 2017</span>, <span id="ref34552383.28813410" class="cite">Mezzadra <em>et al.</em> 2017</span>). As a ligand for the inhibitory receptor PDCD1/PD-1, it modulates the 
activation threshold of T-cells and limits T-cell effector responses. Several  forms of PD-L1 exist expressed on the plasma membrane (mPD-L1), at the surface of secreted cellular exosomes (exoPD-L1), in cell nuclei (nPD-L1), or as a circulating, soluble protein (sPD-L1) (<span id="ref34553680.34204509" class="cite">Bailly <em>et al.</em> 2021</span>). The membrane, exosomal and soluble forms of PD-L1 are parts of the highly dynamic PD-1/PD-L1 signaling pathway. PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination (<span id="ref34555921.36719382" class="cite">Yu <em>et al.</em> 2023</span>).</p>
<p>&nbsp;</p>
<p>&nbsp;</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>PD-L1 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.5.2"></A><A HREF="tcprotein.php?substrate=8.A.23.5.2&tcname=">8.A.23.5.2</a></TD><TD><b><font color=#3333CC><p>V-set domain-containing T-cell activation inhibitor 1 of 282 aas and 2 TMSs, N- and C-terminal.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>V-set domain containing protein of <em>Pteropus giganteus</em> (Indian flying fox)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.23.5.3"></A><A HREF="tcprotein.php?substrate=8.A.23.5.3&tcname=">8.A.23.5.3</a></TD><TD><b><font color=#3333CC><p>Butyrophilin-like protein 2 of 487 aas and 2 TMSs, N- and C-terminal.</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Butyrophilin of <em>Lynx canadensis</em> (canadian lynx)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR></TABLE>
</CENTER>
</BODY>
</HTML>
